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History merely repeats itself. Nothing is truly new; it has all been done or 
said before. What can you point to that is new? How do you know it didn’t 
exist long ages ago? We don’t remember what happened in those former 
times, and in the future generations no one will remember what we have 
done back here. 




In innate and adaptive immunity, the proinflammatory type 1 cytokine interferon 
gamma (IFN-γ), is well known for its protective role particularly against intracellular 
pathogens. However, this type 2 interferon has been implicated in the pathology of 
several diseases. In malaria, it has been demonstrated that IFN-γ exerts both 
protective and pathological roles. In humans and in mouse models, the acute 
infection results in aberrant erythroid differentiation termed dyserythropoiesis which 
contributes to the development of severe malarial anaemia. The mechanism that 
drives this process is poorly understood. However, recent data from our lab suggests 
a role for IFN-γ as the one candidate to mediate the manifestation of early 
dyserythropoiesis. This study aimed to determine the stages of erythropoiesis in the 
bone marrow (BM) and spleen that are perturbed by malaria, and investigate if IFN-γ 
signalling in the haematopoietic compartment alone, is sufficient to promote 
suppression of erythropoiesis during malaria. 
To address the first aim, I used three murine models of experimental malaria which 
differ in virulence, parasite burden, proinflammatory cytokine induction and elicited 
immune response. In all malaria models, I observed an expansion of the erythroid 
progenitors in the bone marrow and spleen, nevertheless, this expansion failed to 
reflect in the number of downstream precursors. Early in infection, there was no 
change in the absolute number of erythroid precursors in infected mice, in 
comparison to naive gender and age matched controls, but at peak parasitaemia at 
the time points sampled, there was a significant contraction in the number of all 
erythroid precursor stages, from the proerythroblast to the orthochromatic 
erythroblast. Furthermore, I observed that this aberration of erythropoiesis in the BM 
and spleen manifests independently of the degree of peripheral parasite burden, 
suggesting a role for proinflammatory cytokines, in particular, IFN-γ in mediating this 
process. 
To further decipher the role of IFN-γ for malaria dyserythropoiesis, I made use of the 
Vav1::iCre/Ifngr2fl/fl mice, which are deficient in IFN-γ signalling specifically in 
haematopoietic cells. I observed that the absolute number of BM lineage negative 
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(LIN—) cells, erythroid progenitors and erythroid precursors was significantly higher 
in Vav1::iCre/Ifngr2fl/fl mice, in comparison to control mice. Interestingly, the absolute 
number of basophilic and polychromatic erythroblasts in infected Vav1::iCre/Ifngr2fl/fl 
mice was significantly higher than in naive mice which was not the case for infected 
control mice. 
Based on these observations, my results suggest that IFN-γ plays a key role in malaria 
dyserythropoiesis by inhibiting the expansion and differentiation of erythroid 
progenitors and precursors, through a direct signalling in haematopoietic cells. In this 
study, I have demonstrated a novel and unpublished method for the identification and 
isolation of erythroid progenitor subsets at high purity and showed for the first time 
in an in vivo setting, that IFN-γ signalling in the haematopoietic compartment alone is 




Malaria is a disease that kills more than 400,000 people annually (1). The malaria 
parasite multiplies in red blood cells and destroys these cells. It has been reported 
that people who have malaria are not able to produce sufficient red blood cells to 
replace the ones that are being destroyed by the parasite. This is because their bone 
marrow (BM), which is where the production of red blood cells occurs, has problems 
in producing new cells. People with this condition could become severely anaemic. 
There are cells in the body that produce a protein called interferon gamma which 
helps other cells fight the malaria parasite. Several studies have demonstrated that 
interferon gamma can suppress the production of red blood cells in the BM. This 
production of red blood cells in the bone marrow occurs in several stages beginning 
with the immature haematopoietic stem cell, which develops through a series of 
intermediate cells to give rise to mature red blood cells in a process called 
erythropoiesis. This process is divided into early and terminal erythropoiesis. 
 In my thesis, I investigated what stages of red blood cell production are affected by 
malaria. At early time points during experimental malaria in mouse, I observed an 
increase in the number of cells involved in early erythropoiesis, and a contraction in 
the number of cells involved in terminal erythropoiesis. This indicated a block in 
erythropoiesis that is, the cells at the early stage were not developing to become the 
cells at the terminal stage. 
To understand if interferon-gamma might be responsible for this, I performed 
experiments in mice that contain a unique class of cells which do not respond to the 
protein. I observed that when I infected these mice with the malaria parasite, the 
number of cells involved in early and terminal erythropoiesis was higher than in 
infected mice in which all the cells could respond to interferon gamma. Interestingly, 
I observed that the number of some of the cells involved in terminal erythropoiesis 
was significantly higher in infected mice that do not respond to interferon gamma, 
than in mice that did not have malaria. 
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These observations suggest that interferon-gamma plays a role in preventing 
sufficient production of red blood cells during malaria, by preventing early-stage 
erythroid cells from developing to red blood cells. It does this by acting on a unique 
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1.1 Haematopoiesis 
The advancement of single cell technologies in the past decades, and identification 
of novel cell surface markers have facilitated the study and understanding of 
mammalian haematopoiesis. Multiparameter flow cytometry and cell sorting, in vitro 
and in vivo clonal assays for haematopoietic stem and progenitor cell functions and 
single cell sequencing, together have allowed the systematic functional 
characterisation and transcriptional profiling of rare and highly purified cells (2). 
Furthermore, the use of conditional gene deletion technologies has permitted lineage 
specific approach in studying various aspects of haematopoiesis in steady state, and 
under inflammatory conditions. 
Haematopoiesis, the step-wise process by which blood cells are formed, has been 
studied extensively for over a century. Haematopoietic cells were first detected in the 
aorta of the developing pig more than 80 years ago (3). Haematopoiesis is highly 
conserved in vertebrates and most of our knowledge of this process has come from 
the use of various animal models, such as the mouse and zebrafish. Haematopoiesis 
occurs in two sequential waves which can be divided into primitive and definitive 
haematopoiesis. 
In primitive haematopoiesis which occurs in the yolk sac, the haemangioblast gives 
rise to myeloid cells and primitive erythrocytes via an erythroid progenitor 
intermediate (4). The primitive wave is transitory and its primary aim is to generate 
erythrocytes to facilitate tissue oxygenation for the rapidly developing embryo (3). 
This wave is characterised by the production of large nucleated erythrocytes that 
express embryonic globins. The switch from primitive to definitive haematopoiesis 
coincides with the switch of the principal site of haematopoiesis from the yolk sac to 
the foetal liver. During the definitive wave in humans, haematopoietic stem cells arise 
in the aorta-gonad-mesonephros (AGM) then seed the foetal liver and bone marrow 
(BM), generating all blood lineages (5). 
The BM, the principal site of definitive haematopoiesis in adults, has a central role in 
maintaining immune homeostasis, and being able to generate and mobilise immune 
cells in response to infection is one of its pivotal function. Haematopoiesis is a tightly 
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regulated process, which is under the control of several transcription factors and 
haematopoietic cytokines. Microbial infection can result in the production of systemic 
cytokines such as type I and type II interferons at distal sites that could cause 
profound changes in the BM, resulting in aberrant haematopoiesis (6). 
1.1.1 Steady state haematopoiesis 
Haematopoiesis is a complex but well-ordered process in which long term 
repopulating haematopoietic stem cells (LT-HSCs) proliferate (self-renew) and 
differentiate to give rise to all mature blood cell lineages via intermediate progenitor 
populations. Under normal physiological conditions, this process occurs primarily in 
the BM of an adult organism. 
Transplantation studies in mice have shown that a single LT-HSC is able to 
reconstitute and maintain all haematopoietic lineages in lethally irradiated mice 
throughout their life-time. Under homeostatic conditions, LT-HSCs are thought to be 
largely quiescent (7–10). Quiescence has been postulated to prevent HSCs from 
exhaustion (7) and to protect against the acquisition of mutations (11). LT-HSCs are 
rare cells and in mice constitute ~ 0.005% of BM mononuclear cells. Their location at 
the apex of the haematopoietic hierarchy and their ability for indefinite self-renewal 
and multilineage differentiation makes these cells the foundation pillars of 
haematopoiesis. 
Akashi et al. proposed a model describing this multilineage differentiation of LTHSC 
to terminally differentiated blood cells in what is now known as the “classical” model 
of haematopoiesis (12). Since then, several alternative models of haematopoiesis 
have been proposed using different surface markers and techniques, and to date, 
there exists no general consensus on the “true” model of haematopoiesis. 
In the classical model of haematopoiesis, LTHSCs differentiate first into highly 
proliferative short-term repopulating HSCs (STHSCs). Both the LTHSCs and STHSCs 
express the tyrosine kinase receptor c-Kit (CD117) and the membrane glycoprotein 
stem cell antigen 1 (Sca-1), but are lineage negative (LIN—), that is, they lack markers 
of terminal differentiation (CD4, CD8, CD11c, CD11b, CD19, B220, Gr1, NK1.1 and 
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Ter119). Despite these cells being part of the LIN— Sca1+ c-Kithi (LSK) fraction of the 
BM, the STHSCs differ from the LTHSCs both functionally and phenotypically. 
STHSCs are capable of limited self-renewal and short-term reconstitution of lethally 
irradiated recipients. In mice, STHSCs also express the cell surface marker CD34 
which is absent on LTHSCs (13). Oguro and colleagues showed that LTHSC (HSC1) 
are CD229-/low whereas STHSC (HSC2) are CD229+(10). No single specific marker is 
known by which HSCs can be identified. Kiel et al. (14) demonstrated that single 
HSCs (LSK, CD150+, CD48—) competitively reconstituted into irradiated mice gave 
rise to long term reconstitution whereas HSCs isolated as LSK Thy1lo did not. In 
conjunction with the LSK definition, LTHSCs are identified by four members of the 
signalling lymphocytic activation molecule (SLAM) family namely, SLAMF1 (CD150), 
SLAMF2 (CD48), SLAMF3 (CD229) and SLAMF4 (CD244) and are LSK CD150+, 
CD48— CD229—/low CD244— (10). 
STHSCs irreversibly lose their self-renewal potential, giving rise to a population 
termed multipotent progenitors (MPPs) (15). MPPs are also part of the LSK fraction 
of the BM. Expression of CD135 in MPPs is associated with loss of long term myeloid 
reconstituting potential (16). A recent model of haematopoiesis shows that STHSCs 
also branch out early to give rise to the megakaryocytic/erythroid pathways via an 
intermediate population termed pre-MEP (17). The pre-MEP undergoes further 
differentiation steps to give rise to platelets and erythrocytes via several intermediate 
progenitor populations. 
Several subsets of MPPs have been described in the literature, with each subset 
exhibiting some bias towards specific lineage commitments (15,18). In general, MPPs 
irreversibly commit to three differentiation pathways namely the myeloid pathway via 
the common myeloid progenitor, the lymphoid pathway via the common lymphoid 
progenitor and the megakaryocytic/erythroid pathway via the pre-MEP (15). The 
myeloid pathway gives rise to granulocytes, monocytes and dendritic cells, while the 
lymphoid pathway gives rise to B cells and NK cells in the BM.  
 
 





NK cells Platelets Erythrocytes Granulocytes Macrophages DC B cells 
































Lin— Sca1+ c-Kithi FLK2— CD150+ CD48— 
Lin— Sca1+ c-Kithi FLK2— CD150— CD48— 
Lin— Sca1+ c-Kithi FLK2hi 
CD150— CD48+ 
Lin— Sca1+ c-Kithi FLK2— 
CD150— CD48+ 
Lin— Sca1— c-Kithi IL7Rα— CD34+ 
CD16/32lo CD150—Tie2+ 
 
Lin— Sca1— c-Kithi IL7Rα— CD16/32lo 
CD150+Tie2+ 
 
Lin— Sca1— c-Kithi IL7Rα— CD34— 
 CD16/32lo  
 
Lin— Sca1— c-Kithi IL7Rα— CD34+ 
 CD16/32hi  
 
Lin— Sca1lo c-Kitlo IL7Rα+ FLK2hi 
Lin— c-Kithi  FLK2hiCD4—CD8α—CD25— 
Lin— Sca1— c-Kithi IL7Rα— CD34+ 
 CD16/32lo CD150—Tie2— 
  
 
  CHAPTER 1 
 6 
Figure 1.1 The revised model of steady state haematopoiesis 
Adapted from Pietras et al., 2015 (15) 
In this revised model of haematopoiesis, LTHSCs give rise to STHSCs and this step is accompanied 
with some loss of self-renewal potential. The STHSCs produce in parallel, distinct lineage biased MPPs 
namely MPP2, MPP3 and MPP4 which are biased towards megakaryocytic/erythroid, myeloid and 
lymphoid commitment respectively. These MPPs are devoid of self-renewal potential. The solid and 
dashed arrows depict the main and alternative differentiation pathways respectively. Abbreviations: 
Long term haematopoietic stem cells (LTHSC), short term haematopoietic stem cells (ST HSC), 
multipotent progenitors (MPP), common myeloid progenitor (CMP), pre-megakaryocyte` erythroid 
progenitor (Pre-MEP), pre-granulocyte macrophage progenitor (Pre-GM), common lymphoid 
progenitor (CLP), megakaryocyte erythroid progenitor (MEP), granulocyte-macrophage progenitor 
(GMP), early thymic progenitor (ETP), dendritic cells (DC), Natural killer (NK) cells. 
 
1.1.2 Erythroid progenitors and precursors 
In the classical model of haematopoiesis, a bipotent CMP lacking lymphoid potential, 
gives rise to both a megakaryocyte-erythroid progenitor (MEP) and a 
granulocyte-macrophage progenitor (GMP). This has been a useful working model 
but is likely an oversimplification. 
Several studies over the last decade have revised this model through the 
identification of alternative differentiation pathways and subpopulations within the 
previously defined progenitor stages. Recent studies have suggested that the 
differentiation into the megakaryocytic/erythroid lineages could be an event upstream 
or in parallel to the generation of CMP (15). 
Downstream of the MPPs, the most primitive population with megakaryocytic and 
erythroid potential but lacking myeloid potential is the pre- megakaryocytic erythroid 
progenitor also known as pre-MEP (17,19). In in vitro clonal assays, the pre-MEP 
(Lin— Sca-1— c-Kithi CD150+ CD105— CD135—) gave rise to megakaryocytic, erythroid 
and mixed megakaryocytic/erythroid colonies but failed to produce any myeloid 
colonies (19). Downstream of the pre-MEP is the MEP (Figure 1.2). Using CD150 and 
Endoglin (CD105), Pronk et al. demonstrated that the MEP described by Akashi et al. 
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as Lin— Sca-1— c-Kithi CD34—CD16/32— (12) is indeed a heterogenous population that 
contains a CD150+ subset the pre-MEP, which I have mentioned above, and a 
CD150— subset (19). This heterogeneity of the MEP has also been demonstrated in 
human studies (20,21).   
The MEP differentiates into the earliest erythroid restricted progenitor, the burst 
forming unit erythroid (BFU-e) cell. The BFU-e is highly motile and it is hypothesised 
that it migrates towards CD169+ macrophages located in specialised BM niches 
called erythroblastic islands, where upon its differentiation to the erythropoietin 
sensitive colony forming unit erythroid (CFU-e) cell, adheres to the macrophage 
through a number of different molecules such as b1 integrins, CD44, Lu and ICAM 4 
(22–24). The BFU-e and CFU-e have been traditionally identified by their morphology 
in clonogenic assays (25–29). This differentiation from the LTHSC to the CFU-e is 
referred to as early erythroid differentiation. Terminal erythroid differentiation involves 
the differentiation of the CFU-e through four distinct erythroblasts stages 
(proerythroblast, basophilic erythroblast, polychromatic erythroblast and 
orthochromatic erythroblast), to the reticulocyte and ultimately terminal red blood cell 
formation. Socolovsky and colleagues pioneered the identification and isolation of 
the distinct erythroblast stages in the spleen and foetal liver, on the basis of the 
expression of the transferrin receptor (CD71) and the red cell membrane protein 
(Ter119) in these populations (30,31). Another parameter, cell size (FSC) was later 
included to improve the identification of these populations in the spleen and BM (32). 
Despite the addition of FSC, the gating strategy employed could only identify three 
of the four erythroblast populations that express CD71 on their surface, namely 
proerythroblast (CD71hi Ter119int), Ery A (CD71hi Ter119hi FSChi) and Ery B (CD71hi 
Ter119hi FSClo) (32). The Ery A population comprised of basophilic erythroblasts while 
the Ery B population comprised of late basophilic and polychromatic erythroblasts 
(32). However, Chen et al. using same markers but a different gating strategy, 
described a more comprehensive breakdown of these erythroid populations that 
included all four erythroblast populations and reticulocytes (33). Furthermore, Chen 
et al. replaced CD71 with CD44 and isolated erythroblast populations at a higher 
purity (33). 
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Terminal erythropoiesis is unique in that proliferation occurs simultaneously with 
differentiation. It is well established that under physiological conditions, a single 
proerythroblast undergoes three mitotic divisions to produce sequentially, two 
basophilic erythroblasts, four polychromatic erythroblasts and eight orthochromatic 
erythroblasts (34). Thus, the ratio of proerythroblasts: basophilic erythroblasts: 
polychromatic erythroblasts: orthochromatic erythroblasts follows a 1:2:4:8 pattern 
(34). This ratio is maintained as a result of the tight regulation of erythropoiesis by an 
array of transcription factors, haematopoietic cytokines, growth factors, adhesive 
receptors and miRNAs. How this ratio is altered could identify potential pathology in 
terminal erythroid differentiation and could provide useful insight into the molecular 
basis of inherited and acquired anaemias. 
1.1.3  Key regulators of erythropoiesis. 
The differential expression of transcription factors is considered operational in 
directing cells towards a particular development fate. Some transcription factors of 
crucial importance for erythroid lineage commitment are Erythroid Krüppel like factor 
(EKLF/KLF1),  GATA binding factor 1 (GATA-1), friend of GATA-1 (FOG1) and PU.1. 
(KLF1/EKLF) is a master regulator of terminal erythroid differentiation, and controls 
cell division, membrane stability, heme and globin synthesis, and iron metabolism 
(35–37). KLF1 knock out mice die of anaemia at embryonic day 16 (E16) 
demonstrating a non-redundant role of KLF1 for erythroid development (35,38). Klf1- /- 
erythroblasts completely fail to enucleate due to a block at the orthochromatic stage 
of terminal differentiation (39). KLF1 regulates the switch from foetal (gamma) globin 
to adult (beta) globin through the activation of Bcl11a, which encodes a repressor of 
gamma globin gene transcription (40,41). Klf1-/- primary erythroid cells fail to enter the 
S phase efficiently (42,43). KLF1 regulates the transcriptional expression of the 
transferrin receptor (Tfrc) as well as a majority of enzymes required for heme 
synthesis (44). 
GATA-1 and GATA-2 are members of the evolutionary conserved GATA transcription 
factor gene family which bind to the DNA consensus sequence (A/T)GATA(A/G) by 
two characteristic C4 (Cys-X2-Cys-X17-Cys-X2-Cys) zinc-finger motifs specific to the 
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GATA family (45,46). GATA-1 is expressed in erythroid cells (47), megakaryocytes 
(48), eosinophils (49) and mast cells (48). Similar to the phenotype seen in KLF knock 
out mice, GATA-1 null mice die from severe anaemia between embryonic day 10.5 
(E10.5) and E11.5(47). GATA-1 null erythroid cells do not mature beyond the 
proerythroblast stage (50) and these arrested erythroid precursors die by 
apoptosis (51). Furthermore, the anti-apoptotic gene Bcl-XL is a direct target of 
GATA-1 (52). 
GATA-2 is highly expressed in HSCs and MPPs. However its expression decreases 
with opposing increase in GATA-1 expression (53). It is thought that this incremental 
expression of GATA-1 is required for the formation of erythroid progenitors. GATA-1 
switches off GATA-2 controlled early progenitor genes and activates terminal 
maturation genes, failure of which promotes megakaryocyte commitment at the 
expense of erythroid commitment (54). 
Using the inducible myxovirus  resistance -1-Cre (Mx1-Cre) and Poly I:C system, 
conditional deletion of  Zfmp-1 which encodes FOG-1, was shown to prevent 
specification of all megakaryocyte and erythroid progenitors while the conditional 
deletion of Gata-1 was indispensable for pre-MEP commitment to an erythroid fate 
but dispensable for commitment towards a megakaryocytic fate (55). 
PU.1 encoded by Spi1 is a member of the ETS family of transcription factors, and is 
expressed exclusively in haematopoietic cells (56–58) but its role for erythropoiesis 
still remains controversial. There is experimental evidence suggesting that PU.1 is not 
essential for erythropoiesis; in two PU.1 deficient mouse lines generated 
independently, terminally differentiated erythrocytes were present in the 
foetuses (59,60). However, in one of these lines, the embryos exhibited a reduced 
number of reticulocytes and erythrocytes (60). This incidence of anaemia was linked 
to the genetic background of the mice and was abrogated by back crossing the Spi1-/- 
mutation onto a C57BL/6 (61). There is however some evidence of a role of PU.1 for 
erythroid development. Using PU.1 deficient mice with a knock-in of an enhanced 
green fluorescent protein (EGFP) in the Spi1 locus, it was demonstrated that foetal 
erythroid progenitors undergo proliferation arrest, premature differentiation and 
apoptosis (62). 











Figure 1.2 Scheme of bone marrow erythropoiesis in steady state 
The decision of whether the megakaryocyte-erythroid progenitor should commit to an erythroid or 
megakaryocytic fate is controlled by an array of transcription factors and microRNAs. GATA-1, FOG-1, 
EKLF, c-Myb, LRF, SCL and miR451 direct erythroid lineage  commitment and progression to 
erythroblasts while GATA-2 and miR150 direct megakaryocytic lineage commitment. Abbreviations: 
GATA-binding factor 1 (GATA-1), friend of GATA-1 (FOG-1), erythroid krüppel like factor (EKLF), 
leukemia/lymphoma-related factor (LRF), stem cell leukemia  (SCL). Adapted from Chen et al., 2019 
(33) and Doré et al., 2011(63). 
1.1.4  Stress induced haematopoiesis 
It is well known that systemic infection with a variety of pathogenic microorganisms 
can result in profound alterations in the phenotype and functional potential of BM 
haematopoietic stem and progenitor cells (HSPCs). These alterations appear to be 
part of a conserved host response to microbial challenge. 
Systemic challenge often elicits a stress induced haematopoietic response that is 
characterised by increased BM output of cells of the myeloid lineage and the 
mobilisation of BM neutrophils to peripheral tissues. This rapid response in which 
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myeloid progenitors are induced to proliferate under stress conditions is termed 
emergency granulopoiesis. 
In malaria and toxoplasmosis, in addition to emergency granulopoiesis, there is a 
transient decrease in lymphocytes, megakaryocytes and erythrocytes despite low 
parasite burden in this site (64–66). The suppression of erythropoiesis and 
development of anaemia is characteristic of many infections. Studies in our laboratory 
using a model of Plasmodium chabaudi malaria, showed a contraction of the erythroid 
lineage restricted progenitors, the BFU-e and CFU-e at early time points during 
infection (67), as well as a decrease in both the frequency and absolute numbers of 
myeloid progenitors. This contraction of myeloid progenitors was dependent on 
indirect IFN-γ signalling (68). 
Ehrlichia muris infection of C57BL/6 was accompanied by major changes in BM 
function, with an almost complete loss of the BFU-e, marked reduction in BM 
erythroid precursors (Ter119+ BM cells), myeloid progenitors and B lymphocytes, and 
a significant decrease in BM cellularity. This was accompanied by the manifestation 
of severe anaemia and thrombocytopenia despite an increase in splenic erythroid 
precursors, (69). These changes were not associated with the presence of the 
bacteria in the BM. 
However, a study in anaemic children under the age of five showed an association 
between the presence of Plasmodium falciparum and hemozoin in BM, with 
ineffective erythropoiesis (70). Microscopic examination of BM smears from these 
children revealed dyserythropoietic features such as nuclear pyknosis and irregular 
nuclei. These features were more prevalent in BM containing hemozoin, while 
erythroid hyperplasia was more prevalent in BM with parasites. Ineffective 
erythropoiesis was confirmed by reticulocytopenia (< 0.5% reticulocytes in peripheral 
blood) and reticulocyte production index (RPI) of less than 1. The RPI is used as a 
marker in the diagnosis of anaemia and also in the determination of the erythropoietic 
response to anaemia. It is a standard measure of the production of reticulocytes and 
takes into consideration both the degree of anaemia and the early release of 
reticulocytes from the BM into circulation in patients with anaemia. An RPI < 2 
indicates an inadequate response to anaemia. In another study in Gabon in which 39 
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individuals were diagnosed with severe malarial anaemia (SMA) with a mean 
haematocrit (HCT), haemoglobin (Hb) concentration and parasitaemia of  14.3%, 
4.9 g/dL and 1.2 x 104 µL-1 respectively, the mean RPI was 0.7 indicating a grossly 
inadequate erythropoietic response to anaemia in these individuals (71) 
Toxoplasma gondii infection in WT C57BL/6 mice resulted in decreased red blood 
cell production that was characterised by a marked reduction in the number of 
reticulocytes which was completely abolished in IFN-γ KO and IFN-γR KO mice (72). 
From these studies, most of the changes that occur in the BM during infection could 
result from the direct presence of the parasite and/or parasite products in the BM or 
could be immune mediated as a result of the production of cytokines at distal sites, 
the latter might perhaps be the most common scenario. 
Many infections are characterised by high systemic levels of IFN-γ, IL1 and tumor 
necrosis factor alpha (TNF-a), and these cytokines have been linked to alterations in 
BM haematopoiesis. IFN-γ is able to modify myelopoiesis (9,67,68,73) and other 
aspects of haematopoiesis (74). IFN-γ can activate quiescent HSCs during infection 
with Mycobacterium avium (75), and together with TNF-a, has been implicated in the 
suppression of erythropoiesis. 
1.2  Malaria 
Malaria is the most important parasitic disease of humans (76). The aetiological agent 
is a unicellular apicomplexan obligate parasite of the genus Plasmodium. There are 
six species of Plasmodium that commonly infect man (P.falciparum, P.vivax, 
P.malariae, P.ovale curtisi, P.knowlesi and P. ovale wallikeri), all of which can cause 
anaemia. This disease is vector borne and is transmitted by Anopheles mosquitoes 
in 108 countries which are inhabited by half the world’s population (76). 
In 2017, there were an estimated 219 million cases of malaria worldwide, which 
resulted in 435,000 deaths (WHO 2018). The vast majority of morbidity and mortality 
is caused by Plasmodium falciparum and was implicated in 99.7% of cases in 2017. 
Children under the age of 5 remain the most vulnerable group and in 2017 accounted 
for 61% of all malaria deaths world wide (WHO 2018). 
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1.2.1  The biology of Plasmodium parasites 
The life cycle of Plasmodia (summarised in Figure 1.3) is characterised by an 
exogenous sexual phase named sporogony, in which multiplication occurs in several 
species of Anopheles mosquitoes and an endogenous asexual phase named 
schizogony which takes place in the vertebrate host (77). In the asexual phase, about 
15-123 motile sporozoites from the salivary duct of an infected female Anopheles 
mosquito are inoculated into a suceptiible host’s subcutaneous tissue during a blood 
meal (78–81). The sporozoites migrate and enter the parenchymal cells of the liver. In 
the vertebrate host, the life cycle of Plasmodium is characterised by a tissue phase 
in the liver, and the erythrocytic phase which is responsible for the appearance of 
clinical manifestations. In hepatocytes, the sporozoites undergo their development 
and multiplication to become a tissue schizont containing thousands of merozoites 
in a process known as pre-erythrocytic or exo-erythrocytic schizogony. The mature 
schizont ruptures together with the infected hepatocytes, releasing merozoites into 
the blood where they invade erythrocytes. Within infected erythrocytes, the 
merozoites replicate and mature progressively from ring-stage parasites to 
trophozoites then to schizonts. The erythrocyte eventually ruptures, releasing 
between 8 and 32 merozoites, that in turn invade new erythrocytes to repeat the 
cycle (82). The asexual cycle in the blood takes approximately 48h for P.falciparum, 
P.vivax and P.ovale, 72h for P.malariae and 24h for P.knowlesi (76). 
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Figure1.3 Life cycle of Plasmodium parasite in the mosquito and vertebrate 
hosts 
Sporozoites from the salivary duct of a Plasmodium-infected female Anopheles mosquito are 
deposited into the subcutaneous tissues during blood meal. Motile sporozoites migrate from the 
dermis to the liver via the blood stream and invade hepatocytes via interactions between Plasmodium 
circumsporozoite protein and heparan sulfate molecules on hepatocytes. Infected hepatocytes release 
tens of thousands of merozoites and merosomes (membrane-bound packets of merozoites) into the 
bloodstream which invade red blood cells. Merozoites undergo repeated rounds of asexual replication 
and a minor proportion of merozoites differentiate into male and female gametocytes. The 
gametocytes can be ingested by another female Anopheles mosquito and in the midgut, the male and 
female gametocytes fuse and develop into a motile ookinete then into oocyts. Oocyts give rise to 
sporozoites which migrate to the salivary gland for transmission to a new host. Adapted from Kurup 
et al., 2019 (83). 
1.2.2 Clinical syndromes of severe malaria 
Malaria disease can be categorised as uncomplicated or severe. Severe malaria 
occurs when infections are complicated by serious organ failures and abnormalities 
in patients blood or metabolism. Almost all severe forms and deaths from malaria are 
caused by P. falciparum, nevertheless, non-falciparum species such as P. vivax and 
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P. knowlesi are also able to cause severe disease (84,85). The major complications 
of severe malaria include cerebral malaria, severe anaemia, pulmonary oedema, 
acute renal failure, metabolic acidosis and hypoglycemia. In sub-Saharan Africa, 
children with severe malaria typically present with one complication such as 
respiratory distress, convulsions or severe anaemia (86).  
In areas of high P. falciparum transmission intensity, the risks of developing severe 
disease are highest in the first two years of life and decline rapidly thereafter. 
Conversely, in low to moderate transmission settings, the period of risks is much 
extended up to the age of five. At the lowest end of the transmission spectrum, the 
risks of severe disease appear to be spread evenly throughout childhood (87). 
Furthermore, the presentation of severe disease changes from severe anaemia in 
children between 1 and 3 years in areas of high transmission intensity to celerbral 
malaria in older children in areas of lower transmission intensity (87). In malaria-
endemic areas where transmission is stable, severe malaria is unlikely to occur after 
five years of age due to naturally acquired immunity (NAI). Also, infants remain 
remarkably resistant to severe disease until about 6 months of age. This protection is 
thought to be associated with the presence of maternal immunoglobulin G antibodies 
and/or parasite growth-inhibitory factors such as lactoferrin and secretory 
immunoglobulin A found in breast milk and in maternal and infant sera (88). NAI to 
severe malaria may be acquired relatively quickly after up to four exposures (88) and 
mathematical models have suggested that protection against non cerebral severe 
malaria develops after one or two infections (89). 
Severe malarial anaemia (SMA) is the main manifestation of severe malaria in young 
children in areas of high transmission intensity (90). In holoendemic P. falciparum 
transmission areas, SMA accounts for 30% of the mortality in children under three 
years of age (91). In a study in 880 young children in Tanzania, transmission season 
at time of delivery and cord blood levels of IL-1β provided the strongest 
discrimination of SMA risk during the first three years of life (92). 
SMA is an outcome of the perturbation of red blood cell homeostasis either as a result 
of a reduced erythroid output from the BM or an increased clearance/destruction of 
erythroid cells. SMA according to the WHO is defined as haemoglobin (Hb) 
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concentration of < 5 g/dL or haematocrit (HCT) of less than 15% with any degree of 
parasitaemia. Rapid haemoglobin reductions of 20 to 50% are commonly observed 
in patients with SMA and they must be rescued by blood transfusion which poses a 
great risk of HIV acquisition, especially in sub-Saharan countries (93). 
According to the literature, patients with SMA have appropriate erythropoietin (Epo) 
response. A study in Gabonese children showed elevated serum Epo concentration 
of 15,364 ± 9984 mU/mL before therapy which declined to basal levels of 
144 ± 180 mU/mL, 28 days after initiation of therapy (94). However, the reticulocyte 
production index (RPI) in these patients remained low considering the degree of 
anaemia.  
The aetiology of SMA is multifactorial and could arise as a result of distinct and 
overlapping features such as clearance and/or destruction of infected and uninfected 
erythrocytes, dyserythropoiesis and erythropoietic suppression (95). These 
mechanishms are present in both humans and mouse models. Destruction of 
uninfected erythrocytes rather than infected erythrocytes is estimated to account for 
most of the loss of erythrocytes during malaria and might explain why parasitaemia 
fails to correlate with SMA.  
 
A desirable feature of mouse models of malaria is that there are four known species 
of rodent malaria parasites namely P. chabaudi, P. vinckei, P. berghei and P. yoelii, 
and various strains such as P. yoelii YM and P. yoelii 17XNL, with each displaying 
unique parasite biology and pathogenicity. P. berghei for example infects mature red 
cells and reticulocytes and is used in the study of experimental cerebral malaria in 
C57BL/6 and CBA/T6 mice, P. yoelii XNL which preferentially invades reticulocytes, 
has been used extensively in multiple strains of mice to study the pathogenesis of 
malaria and immune mechanisms of protection and may serve better as a model for 
P. vivax. The lethal strain P. yoelii YM that infect both reticulocytes and mature red 
cells has been used to test vaccine candidates, and various strains of P. chabaudi 
that infect mature erythrocytes and reticulocytes, and P. vinckei that infect mature 
erythrocytes have been used in different mouse strains to study immune 
mechanisms, pathogenesis and susceptibility to drugs. The course of infection and 
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the immune response are variable among the various mouse models but specific for 
each host-parasite combination (96). 
 
In acute disease, the imbalance between proinflammatory and anti-inflammatory 
mediators may be the main cause of dyserythropoiesis and mouse models able to 
reflect this are those that use P. chabaudi and P. yoelii (96). The P. chabaudi model 
of malaria mirrors many of the pathological and immunological aspects of human 
malaria infections, making it an excellent tool to expand our knowledge of human 
malaria infections and to identify new targets for therapeutic interventions. However 
there are several limitations to this model such as, the organ of sequestration in mice 
(the liver rather than the brain), some differences in pathogenic symptoms such as 
the development of hypothermia rather than fever, and the discrepancy of 
parasitaemia profiles between mice (97). 
 
Severe anaemia is a feature of all mouse models (98) however, the majority of these 
mouse models demonstrate acute malaria infection with parasitaemia that often 
exceeds 20% which is in contrast to SMA in humans in which acute malaria 
commonly occurs with a lower parasitaemia (96). Despite this difference, SMA in 
P. falciparum and P. chabaudi malaria have several features in common. For 
instance, in P. falciparum malaria, patients with SMA and suppressed erythropoiesis 
as evidenced by their low RPI, have a robust erythropoietin response (94), and this 
has also been reported in non-lethal P. chabaudi experimental malaria in C57BL/6 
mice (99). The increased levels of erythropoietin fail to correct the deficit in 
haematocrit caused by haemolysis and erythrocyte sequestration, which suggests a 
non-responsiveness of erythroid cells to erythropoietin stimulation during SMA in 
both P. falciparum and P. chabaudi malaria, a hallmark of dyserythropoiesis. 
 
1.2.3 Dyserythropoiesis in Malaria 
Erythropoietic suppression or dyserythropoiesis is known to occur in humans and in 
mouse models. Two distinct patterns of dyserythropoiesis are observed in humans. 
Acute malaria is characterised by a reduction of erythropoieitic activity, normal or 
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reduced BM cellularity, erythroid hypoplasia and a reduced percentage of 
erythroblasts, while in chronic malaria, BM cellularity and percentage of erythroblasts 
are increased, erythroid hyperplasia is evident and these are associated with 
substantially greater ineffective erythropoiesis than in acute malaria (100). The study 
of disordered erythropoiesis in mouse models has been restricted to the the acute 
phase of the disease and there is paucity of data on dysplastic changes in murine 
erythoid cells during the chronic phase of the disease. Unlike in SMA in humans in 
which no change in BM CFU-e has been reported (98), a transient 50% decrease in 
BM CFU-e was reported in P. chabaudi malaria in C57BL/6 mice (101). This 
remarkable decrease in BM CFU-e was further confirmed by Belyaev and colleagues 
(102). 
In individuals with dyserythropoiesis, erythropoietic suppression could persist for 
weeks after the commencement of drug therapy and well after clearance of the 
parasite (100). This suggests that this phenomenon is not directly driven by the 
parasite itself but rather could be as a result of by-products of parasite metabolism 
such as haemozoin (70,103,104) and/or host derived factors. 
Dyserythropoiesis is characterised by non-responsiveness of erythroid cells to 
erythropoietin (EPO) stimulation (105), this is supported by the low reticulocyte 
production index (106) despite a robust erythropoietin response in children with 
SMA (94). Miller et al. performed experiments demonstrating that an unknown soluble 
factor inhibited erythropoiesis during malaria (105). A number of host derived factors, 
in particular, proinflammatory cytokines namely TNF-a, IFN-γ and macrophage 
migration inhibitory factor (MIF), produced during the immune response to malaria, 
have been implicated as mediators of malaria dyserythropoiesis (107,108). Most of 
these studies have focussed on MIF and TNF-α with only a few on the role of IFN-γ 
for ineffective erythropoiesis during malaria. 
1.3 Mechanisms of erythropoiesis inhibition by IFN-γ 
The proinflammatory cytokine IFN-γ is produced predominantly by natural killer cells, 
natural killer T cells, type 3 innate lymphoid cells, innate B cells and macrophages as 
part of the innate immune response, and by Th1 CD4 and CD8 T cells once 
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antigen-specific immunity develops (109–111). IFN-γ secretion by these cells is 
essential for the control of intracellular pathogens and tumours, however, aberrant 
production of IFN-γ contributes to autoimmunity and inflammation in certain disease 
settings. These divergent roles of IFN-γ are well illustrated in the context of malaria. 
IFN-γ is a central cytokine in controlling Plasmodium infection in both the liver and 
blood stages (112), but depending on its temporal and spatial production, IFN-γ might 
exacerbate the severity of malarial disease, one of such pathological roles of IFN-γ in 
malaria is in mediating anaemia via erythropoiesis suppression. 
There are knowledge gaps in our understanding of the molecular mechanisms by 
which IFN-γ inhibits erythropoiesis during malaria. In a murine model of sterile chronic 
immune activation, IFN-γ induced the expression of PU.1 in MEPs (113) and PU.1 is 
able to interact antagonistically with GATA-1 inhibiting its role in erythroid 
development (114). In this model also, IFN-γ was implicated in the contraction of 
BFU-e colonies and late stage erythroid precursor (113).  
Studies in which IFN-γ induced apoptosis of erythroid cells have been so far only 
performed in vitro. These erythroblast populations alone, deplete of the nourishment 
and survival signals provided by “nurse cells” in erythroblastic islands, are arguably 
more sensitive to IFN-γ ultimately leading to their apoptosis. In one of such studies, 
IFN-γ mediated dyserythropoiesis by induction of Fas (CD95) on highly purified 
human erythroid colony forming cells which constitutively express FasL (115), leading 
to their apoptosis. The concentration of IFN-γ used in this study was extremely high 
(2.5 ngml-1) and might not be obtainable under physiological conditions.  
The downregulation of stem cell factor (SCF) and EpoR on human erythroid colony 
forming cells treated with IFN-γ have been linked to apopotosis in these cells (116). 
IFN-γ upregulated the expression of TNF-related weak inducer of apoptosis (TWEAK) 
and TNF-related apoptosis inducing ligand (TRAIL) in human erythroblasts and these 
death ligands directly mediated programmed cell death, and inhibited the expansion 
and differentiation of these cells (117). 
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It would be interesting to investigate if similar changes in the expression of key 












Figure 1.4 The IFN- γ receptor and its signalling 
Adapted from Zaidi and Merlino, 2011 (118) 
The IFN-γ receptor is made up of two alpha chains and two beta chains. Two kinases Janus 
kinase 1(JAK1) and Janus kinase 2 (JAK2) associate with the intracellular domains of IFN-γ receptor 
alpha chains (IFN-γR1) and IFN-γ receptor beta chains (IFN-γR2) respectively. IFN-γ exists as a 
homodimer and binds solely to IFN-γR1, this binding causes IFN-γR2 to associate strongly with 
IFN-γR1 bringing JAK1 and JAK2 into close juxtaposition such that they cross-phosphorylate each 
other and phosphorylate a tyrosine residue on IFN-γR1 creating a docking site for STAT1. Two parallel 
STAT1 homodimers are recruited to the docking site and their Tyr701phosphorylation by JAK1 and 
JAK2 converts the homodimers into an antiparallel configuration. The reoriented STAT1 homodimers 
dissociate from the receptor and translocate to the nucleus. In the nuclues they bind to gamma 
activated sequence (GAS) sites on the primary response genes and mediate the transcription of 
primary genes including Interferon regulatory factor-1 (IRF1). IRF1 subsequently activates a large 
number of secondary response genes with a wide range of immunomodulatory functions. Acetylation 
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and subsequent dephosphorylation of STAT1 homodimers change their orientation to parallel 
configuration and cause their exit from the nucleus. Suppressor of cytokine signalling  (SOCS-1) is a 
major negative regulator of IFN-γ signalling and inhibits the phosphorylation of JAKs and STAT1. 
 
 
Figure 1.5  Assembly of IFN-γR2 on cell surface 
Adapted from Xu et al., 2018 (119) 
IFN-γR1 is constitutively expressed on the surface of all nucleated cells and is responsible for 
binding IFN-γ. However, IFN-γR2 is induced after inflammation and translocates to the cell 
membrane. The engagement of E-selectin to its ligand provides the initial signal for this 
translocation. Following its engagement, E-selectin activates Bruton’s tyrosine kinase (BTK), which 
phosphorylates tyrosine 289 of IFN-γR2 in the cytoplasm. EFhd2 then binds to the phosphorylated 
receptor to promote its membrane translocation. In the absence of Ifngr2 gene, IFN-γR1 is able to 
bind IFN-γ but downstream signalling is abolished. 
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1.4 Aims of the study 
The primary aim of this PhD work is to investigate the role of IFN-y signalling on the 
aberration of erythropoiesis during malaria. To understand the role of IFN-γ signalling 
for malaria dyserythropoiesis, the accurate identification and isolation of erythroid 
cells at high purity is pivotal. The erythroid and myeloid progenitors are in the same 
developmental subset (LIN—Sca-1—CD117hi), and the surface markers currently in use 
to identify these progenitor populations within the HPC pool, only poorly resolve 
these progenitors and yields low purity of FACS sorted populations. To address this 
problem, I aimed to define novel surface markers that could clearly distinguish the 
myeloid and erythroid progenitors, and yield high purity of FACS sorted populations. 
Having defined novel surface markers that could identify the most primitive and least 
characterised erythroid progenitor, the Pre-MEP, as well as the MEP with a high 
degree of accuracy, I aimed to investigate the exact stages of erythropoiesis that are 
impacted by malaria. Previous studies on malaria dyserythropoiesis had focused on 
stages downstream of the MEP, as the MEP and Pre-MEP were only identified by 
flow cytometry in the recent years. I used three murine models of infection namely, 
the serial blood passage, the mosquito transmission and sporozoite inoculation 
models and observed significant erythroid suppression at multiple stages of 
erythropoiesis in the BM and spleen. 
This led to the final aim to investigate if IFN-γ signalling in the haematopoietic 
compartment alone, is sufficient to promote suppression of erythropoiesis during 
malaria. Studies on dyserythropoiesis have focused mainly on MIF and TNF-α, and 
there is a paucity of data on the in vivo role of IFN-γ for dyserythropoiesis during 
malaria. Furthermore, it remains unknown if the suppression of erythropoiesis by 
IFN-γ is a consequence of a direct signalling in haematopoietic cells or whether it is 
a consequence of IFN-γ signalling in non-haematopoietic compartments. Adopting a 
refined genetic approach, I demonstrated that IFN-γ signalling in the haematopoietic 
compartment alone is crucial for malaria dyserythropoiesis in the BM and spleen.  




MATERIALS AND METHODS 
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2.1 MICE 
Inbred mouse strains used were C57BL/6Jcrl, Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and 
Vav1::iCre mice. Vav1::iCre transgenic mice have the mouse HS21/45 control regions 
directing expression of an optimized variant of Cre recombinase (iCre; improved with 
mammalian codon usage, removed putative cryptic splice sites, altered stop codon, 
and reduced CpG content to limit the chances of epigenetic silencing in mammals) to 
hematopoietic cells and their progenitors (120). The Vav1::iCre/Ifngr2fl/fl mice were 
generated by crossing Vav1::iCre mice with Ifngr2fl/fl mice. Vav1::iCre mouse which 
has a Cre insert in the Vav1 locus was created by de Boer and colleagues(121) and 
was maintained as heterozygous, considering that homozygosity results in 
developmental abnormalities and intraembryonic death around E14.5—16.5. Ifngr2fl/fl 
mice were generated by Anne Fleige and Werner Müller (122). Mice were housed 
under specific pathogen free conditions in the animal facility at the University of 
Edinburgh and were provided with mouse breeder diet and water ad libitum. These 
mice were maintained either under normal light conditions (light 07.00—19.00 : dark 
19.00—07.00) or reverse light conditions (dark 07.00—19.00 : light 19.00—07.00) at 
220C and 50% relative humidity. Mice aged 8 to 12 weeks were used for experiments 
and all experimental mice were back crossed for at least ten generations onto a 
C57BL/6 background. All animal experiments were done in accordance with United 
Kingdom Home Office guidelines. 
2.2 INFECTION MODELS 
Malaria was established in mice using three models of malaria namely, serial blood 
passage, mosquito transmission and sporozoite inoculation models. 
2.2.1 SERIAL BLOOD PASSAGE MODEL 
Frozen stocks of serially blood passaged Plasmodium chabaudi chabaudi AS 
(Pcc AS) up to the 30th passage were kind gifts from Dr. Philip J Spence (Institute of 
Immunology and Infection Research, Ashworth Laboratories, University of Edinburgh) 
and were maintained in liquid nitrogen. Equal volume of Krebs saline + glucose (KSG) 
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was added to frozen stock of Pcc AS, rapidly thawed and 200 µL was injected 
intraperitoneally (i.p) into a single donor mouse. Parasitaemia was monitored by 
examination of thin blood films. At 2-5% parasitaemia, which corresponds to day 7 
post infection, donor mouse was euthanised with 50 µL of Euthatal, 200µL of 
prewarmed heparinized KSG was transferred into the thoracic cavity, the aorta was 
cut and blood was collected using a sterile pastette (123). Blood stage infection was 
established in experimental mice by i.p injection of 1 x 105 Pcc AS parasitised 
erythrocytes isolated from the donor mouse. Parasitaemia was determined by 
counting the number of parasitised erythrocytes in 50 fields of view of approximately 
200 erythrocytes each, which were distributed in a monolayer. The number of 
parasitised erythrocytes was then expressed as a percentage of total erythrocytes. 
2.2.2 MOSQUITO TRANSMISSION MODEL 
Serial blood passaged parasites were transmitted through the mosquito vector 
Anopheles stephensi and donor mice were infected by mosquito bite, with an 
estimated nine infective bites per mouse to establish both liver and blood stages of 
malaria. Vector transmission is assumed to “reset” Plasmodium to its original 
character, regulate gene expression of probable variant antigens in the erythrocytic 
cycle, modify elicited immune response and regulate parasite virulence (124). 
To bypass the pre-erythrocytic stages and control the dose initiating blood-stage 
infection, experimental mice were injected i.p with 1 x 105 Pcc AS parasitised 
erythrocytes obtained from donor mouse. 
2.2.3 SPOROZOITE INOCULATION MODEL 
The isolation of Pcc AS sporozoites and intravenous (IV) injection of sporozoites into 
donor mice were performed by Dr. Wiebke Nahrendorf (Institute of Immunology and 
Infection Research, Ashworth Laboratories, University of Edinburgh). 200 sporozoites 
teased out of the salivary gland of Pcc AS parasitised mosquito vector 
Anopheles stephensi, were injected intravenously into donor mice to establish both 
pre-erythrocytic and erythrocytic stages of malaria. Similar to the mosquito model, to 
bypass the pre-erythrocytic stages and control the dose initiating blood-stage 
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infection, experimental mice were injected i.p with 1 x 105 P. c. chabaudi AS 
parasitised erythrocytes obtained from donor mouse. 
2.3 Preparation of single cell suspension 
Intact femur and tibia free of attached tissue were obtained from culled mice and 
placed in Iscove’s Modified Dulbecco’s Medium (IMDM). Both ends of the bones were 
cut off and the marrow was flushed out using a 5ml syringe fitted with a 27G-needle. 
The flow through was collected and passed through a 27G-needle and through a 
70µm nylon mesh. In other instances, the bone was gently crushed to expose the 
marrow and passed through a 70µm nylon mesh. Spleens were passed through a 
70µm nylon mesh. Cell number per millilitre (mL) was determined using a Casy cell 
counter (Roche Innovatis AG). 
2.4 Physical depletion of lineage positive bone marrow 
cells. 
Single cell suspension of bone marrow (BM) cells were incubated with Mouse 
Seroblock FcR (BIO-RAD) according to manufacturer’s instructions (10µl of 1/10 
dilution per 1 million cells for 10 minutes at 40C), after which cells were washed with 
Fluorescence Activated Cell Sorting (FACS) buffer which is made up of 1x phosphate 
buffered saline (PBS), 2% fetal calf serum (FCS) and 2mM Ethylenediaminetetraacetic  
acid (EDTA). Cells were labelled with a cocktail of biotinylated antibodies against 
lineage antigens (CD3e, CD8a, CD11b, CD11c, CD19, CD45RB, Gr1, NK1.1, Ter119) 
at 40C for 15 minutes in the dark. After washing the cells with FACS buffer, the cells 
were labelled with streptavidin paramagnetic microbeads (Miltenyi Biotec), 
resuspended in degassed magnetic activated cell sorting (MACS) buffer (1x PBS, 2% 
FCS, 1mM EDTA) and passed through an LD separation column (Miltenyi Biotec) 
attached to a varioMACS separation unit. The eluate (LIN— cells) was collected for 
further staining. To identify and/or isolate erythroid precursors, biotinylated 
monoclonal antibodies against Ter119 was excluded from the lineage cocktail. 
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2.5 Preparative and Analytical flow cytometry 
All antibodies used in this study were titrated and used at optimised dilutions. 
7-Amino-Actinomycin D was used to exclude dead cells. Erythroid progenitors and 
myeloid progenitors in bone marrow and spleen were identified by staining of LIN— 
cells with monoclonal antibodies against CD117, Sca-1, CD150, CD27 CD16/32 and 
CD34. To identify erythroid precursors, bone marrow cells and splenocytes depleted 
of lineage positive cells with the exclusion of Ter119+ cells, were stained with CD71 
and Ter119. Cell labelling was done at 40C for 15 minutes in the dark in all cases. 
Samples were acquired on an LSRII Fortessa (BD Biosciences) with BDFACSDiVaÔ 
Software (BD Biosciences). FlowJo (v9.9.6; Tree Star, Ashland, OR) was used for data 
analysis. 
2.6 Electronic exclusion of lineage positive cells 
Single cells from BM were stained with Fc receptor blocking antibody, after which the 
cells were labelled with a cocktail of FITC conjugated monoclonal antibodies against 
lineage antigens. On FlowJo (v9.9.6; Tree Star, Ashland, OR), FITC positive cells were 
gated as lineage positive (LIN+) cells and excluded from further analysis. In other 
instances, biotin conjugated monoclonal antibodies against lineage antigens was 
used to label LIN+ cells. Streptavidin-PerCP-Cy5.5 was then used to electronically 
exclude these cells from further analysis. 
2.7 In vitro erythroid differentiation assay 
CD150+ CD27int and CD150— CD27— haematopoietic progenitor cells were sorted 
using a FACS Aria IIb (Beckton Dickinson) into 5 mL Falconâ round bottom tubes 
containing 1 mL heat inactivated fetal calf serum (Sigma-Aldrich), then centrifuged at 
300xg for 10 minutes at room temperature and resuspended in erythroid 
differentiation medium (EDM), which is Iscove’s Modified Dulbecco’s medium 
(Sigma-Aldrich ) supplemented with 10% foetal calf serum (Sigma-Aldrich), stem cell 
factor (50 ng/ml, PeproTech), erythropoietin (40 ng/ml, R&D Systems), 
thrombopoietin (10 ng/ml, PeproTech), interleukin 3 (10 ng/ml, PeproTech), 
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transferrin (0.1 mg/ml, Merck), a monothioglycerol (10-4 M, Merck), insulin 
(5 µg/ml, Sigma-Aldrich) and Dexamethasone (10-8 M, Sigma-Aldrich). Sorted cells 
were seeded at a density of 1 x 104 cells in independent wells of a 24-well flat-bottom 
plate (Costar®) containing 500 µL EDM for erythroid differentiation. Post sort purity 
was ³ 98%. Plates were kept in an incubator at 370C, 5% C02 and 95% humidity. 
2.8 Blood collection and serum preparation 
Mice were euthanised by inhalation of C02, after which 500-800 µL of blood was 
drawn from the posterior vena cava using a 25G- needle. The blood was allowed to 
coagulate, then centrifuged at 11000 x g for 5 minutes. The yellow supernatant 
(serum) was collected and frozen at -200C. 
2.9 Enzyme linked immunosorbent assay (ELISA) 
Serum samples were analysed for IFN-γ and TNF-α using the mouse IFN-γ and 
Mouse TNF-α ELISA Ready-SET-Go kits (eBioscience, San Diego, CA). Two-fold 
dilutions of samples or standards were incubated with IFN-γ or TNF-α capture 
antibody coated plates. IFN-γ and TNF-α were detected with the provided detection 
antibodies and Avidin-HRP/TMB substrate solution. The reaction was stopped with 
2N sulphuric acid and plates were read on a 96-well ELISA plate reader at 450nm 
wavelength. The data was converted to concentration (pg. mL-1) using the IFN-γ and 
TNF-α standard curves. 
2.10 DNA extraction 
Mouse tail sample was suspended in 500 µL tail lysis buffer (100mM Tris-HCl, pH8.8; 
5mM EDTA pH8.0; 0.2%SDS; 200mM NaCl; proteinase K 100 µg/mL) and incubated 
overnight on an Eppendorf Thermomixer® at 550C with agitation at 300rpm. Sample 
was then vortexed and centrifuged at 20800 x g for 10 minutes, after which 475 µL 
supernatant was resuspended in new tube containing 950 µL of ice-cold ethanol 
(neat) to precipitate DNA. Sample was centrifuged at 20800 x g for 10 minutes, 
supernatant was discarded and mouse DNA was air-dried for at least 1 hour. Mouse 
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DNA was then resuspended in 50 µL molecular biology grade water (Merck) for PCR 
analysis. 
2.11 Polymerase chain reaction (PCR)  
Hot start PCR was used solely for genotyping animals. Reactions were carried out in 
0.2 mL PCR tubes (Axygen), each reaction consisted of 4 µL of 5X PCR buffer 
(Promega), 1.6 µL of 25mM magnesium chloride (Promega), 0.4 µL 10mM dNTP mix, 
0.2 µL Taq DNA polymerase (5 U/µL, Promega), 1 µL of template DNA (50-100 
ng),1 µL each of forward and reverse primers at 10 pmol/µL for iCre PCR or 1 µL each 
of loxP1, loxp2 and loxp-site primers at 10 pmol/ µL for Ifngr2fl/fl PCR. Molecular 
biology grade water (Merck) was added to a final volume of 20 µL. 
Tubes were placed in a PTC-200 DNA engine thermal-cycler (BIO-RAD) and run on a 
PCR programme based around the following: Reactions were initially denatured at 
940C for 3 minutes and 30 seconds, after which GoTaq® flexi DNA polymerase 
(Promega) was added to reaction tubes. They were then cycled 31 times through a 
programme of denaturing at 940C for 40 seconds, then annealing at 620C for 30 
seconds, then an extension of 30 seconds at 720C. After 31 cycles, there was a final 
extension step of 5 minutes at 720C. The reaction was stopped by a rapid cooling to 
40C. 12 µL of PCR products were analysed by agarose gel electrophoresis at 100 V 
for 1 hour. 
2.12 Screening for lox-p (locus of crossover in phage P1)-
flanked alleles and Cre expression 
In generating the Ifngr2fl/fl mice, two loxP sites were inserted in the Ifngr2 locus. One 
loxP site was inserted between exons 3 and 4 and the other between exons 6 and 7 
using a pBluescript II SK targeting vector (Figure 2.1A). In detail, the targeting vector 
for Ifngr2 was constructed using the RED/ET cloning system (Gene Bridges). A loxP 
flanked neomycin cassette and an xho1 site was inserted between exons 3 and 4 by 
ET cloning. Then an 8 kb long fragment of the Ifngr2 gene, containing the region from 
exon 2 to exon 7 was subcloned into pBluescript II SK. The plasmid was then 
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transfected into Cre recombinase expressing bacteria. The neomycin resistance 
marker gene was removed, leaving one loxP site with an xho1 site in the modified 
gene. Subsequently a FRT (flippase recognition target)-flanked neomycin gene with 
one loxP site was inserted after exon 6. After verification, the targeting vector was 
transfected into IDF32F1 embryonic stem (ES) cells (C56BL/6 × 129S1). The ES cell 
clones were screened by southern blotting with a probe of exon 7 of the Ifngr2 gene 
after xho1 restriction digest. One clone, F5, was selected and used to generate 
chimeric mice. Germline transmission was obtained and the FRT flanked neomycin 
gene was removed by breeding the mice to FLP (flippase) deleter mice (122). Primers 
were designed to anneal in such a manner that yields 392 bp and 191bp PCR 
products in Ifngr2fl/fl mice and a 276bp PCR product in Ifngr2wt/wt mice (Figure 2.1B 
and Appendix A and B). 
Vav1::iCre mice were bred to heterozygosity as recommended (125), and primers 
were designed to amplify a 236bp sequence unique to Cre recombinase. After PCR, 
genomic DNA from Vav1::iCre mice yielded the expected product of 236 bp while 


























Figure 2.1  PCR for lox-p flanked alleles and Cre expression 
(A) Schematic representation of the Ifngr2  targeting strategy. Agarose gels showing (B) 276bp PCR 
product which represents Ifngr2wt/wt mice (lane 2), and 392bp and 191bp PCR products which 
represent Ifngr2fl/fl mice (lanes 3-13). (C) 236bp PCR product which represents Vav1::iCre mice. 
Negative and positive controls are shown in lanes 2 and 3 respectively. 100bp ladder (lane 1) was used 
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2.13 Statistical analysis 
Statistical analysis was performed using the GraphPad Prism software. Means 
between two groups were compared using two-tailed unpaired Student’s t-test. 
Groups of three or more means were compared using one-way analysis of variance 
and the Tukey multiple comparisons test. Normal distribution of data was tested 
using the Shapiro-Wilk test. P values ≤ 0.05 were considered statistically significant. 
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 Table 2.1: mAb clones and suppliers 
Antigen Name Dilution Clone Fluorochrome Supplier 
CD3ε  1:200 145-2C11 FITC, Biotin eBioscience 
CD8α Ly2 1:200 53-6.7 FITC, Biotin eBioscience 
CD11b  1:200 M1/70 FITC, Biotin eBioscience 
CD11c Integrin aX 1:200 N418 FITC, Biotin eBioscience 
CD16/32 FcγII/III receptor 1:400 93 PE-Cy7 eBioscience 
CD19  1:200 1D3 FITC, Biotin  eBioscience 
CD27  1:500 LG.7F9 PE, APC eBioscience 
CD34  1:100 RAM34 FITC eBioscience 
CD45R B220 1:200 RA3-6B2 FITC, Biotin eBioscience 
CD71 Transferrin 
receptor 
1:2000 R17217 PE eBioscience 
CD117 c-Kit 1:200 2B8 APC-eFluor 780 eBioscience 
CD127 IL-7Rα 1:200 A7R34 FITC, Biotin eBioscience 
CD135 Flk-2 1:50 A2F10 PE eBioscience 
CD150 SLAM 1:500 TC15-
12F12.2 
APC, PE-Cy7 BioLegend 
Gr-1 Ly6G 1:200 RB6-8C5 FITC, Biotin eBioscience 
NK1.1 Ly55 1:200 PK136 FITC, Biotin eBioscience 
Ter-119 Ly76 1:200 TER-119 FITC, Biotin eBioscience 
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Antigen Name Dilution Clone Fluorochrome Supplier 
Ter-119 Ly76 1:200 TER-119 APC BioLegend 
Sca-1 Ly6A/E 1:200 D7 Pacific Blue, BV 421 BioLegend 




 1:10 FCR4G8 
 
 BIO RAD 
 
Table 2.2 Primer sequences 
Primer name Sequence 
iCre forward 5’-AGA TGC CAG GAC ATC AGG AAC CTG-3’ 
iCre reverse  5’-ATC AGC CAC ACC AGA CAC AGA GAT C-3’ 
LoxP1 5’-TGA GTT CCA AGC AAG ACA GA-3’ 
LoxP site 5’-AAG TTA TGG TCT GAG CTC GC-3’ 
LoxP2 5’-CAG GGT AGA AAA GAT GTG CA-3’ 




ERYTHROPOIESIS IN STEADY STATE 
  
  CHAPTER 3 
 36 
3.1 Introduction 
The pool of haematopoietic progenitor cells (HPC) act as a critical population for 
lineage specification between the haematopoietic stem cells (HSCs)/multipotent 
progenitors (MPPs), and more mature erythroid, megakaryocytic and myeloid cells. 
The HPCs are defined as lineage negative (LIN—) and have a high surface expression 
of CD117/c-KIT but unlike the HSCs and MPPs, they do not express Sca-1 on their 
surface in steady state (12). The HPC compartment contains at least three different 
progenitor populations, which are the CMP (CD16/32lo CD34+), MEP (CD16/32lo 









Figure 3.1  Haematopoietic progenitor cells in steady state 
The pool of haematopoietic progenitor cells is made up of CMP, GMP and MEP and arise from the 
differentiation of multipotent progenitors which reside in the LSK pool. This differentiation is coupled 
with loss of surface expression of stem cell antigen 1 (Sca-1). Abbreviations: LSK; LIN—Sca-1+c-KIThi, 
HPC; haematopoietic progenitor cells, LTHSC; long-term haematopoietic stem cell, STHSC; 
short-term haematopoietic cells, MPP; multipotent progenitors, CMP; common myeloid progenitor, 
GMP; granulocyte-macrophage progenitor, MEP; megakaryocyte-erythroid progenitor, CLP; common 
lymphoid progenitor. 
Lineage neg. (LIN–)  
Bone Marrow 
HPC LSK 





















  CHAPTER 3 
 37 
The surface markers currently in use to identify the erythroid and myeloid progenitors 
within the HPC, namely CD16/32 and CD34 only poorly resolve these populations 
with no clear-cut demarcation of myeloid progenitors that express CD34 on their 
surface from erythroid progenitors that do not, resulting in an operational problem of 
how to separate successfully overlapping subpopulations. The inability to isolate 
erythroid progenitors at a high purity has limited the study of erythropoiesis to more 
mature erythroid populations such as the BFU-e and CFU-e which are identified 
based on their morphology in clonogenic assays. 
To address this problem, I aimed to find novel surface marker combinations that 
could better resolve the HPC pool into distinct myeloid and erythroid progenitors. In 
addition, the surface expression of such markers would have to be stable during 
infection. Next, I confirmed using in-vitro functional assays that the erythroid 
progenitors I identified using these novel marker combinations are bona fide erythroid 
progenitors.  
In this chapter, I performed phenotypic profiling of BM erythroid and myeloid 
progenitors in steady state, using markers known from literature to be connected to 
erythroid and myeloid commitment. I also characterised and quantified BM erythroid 
precursors using the most recent gating strategy (34), to confirm that the 1:2:4:8 ratio 
of erythroblast maturation is maintained in steady state, which reflects the 
physiological progression of terminal erythroid differentiation in mice. 
3.2 Defining haematopoietic progenitors in the adult BM in 
steady state 
The HPC constitutes a rare pool of LIN— BM progenitors and identifying them requires 
the physical depletion or electronic exclusion of LIN+ cells. In this experiment, naïve 
female C57BL/6 mice aged 8 to 12 weeks were used. A pair of femur and tibia was 
isolated from each of three mice and single-cell suspensions of BM cells were 
prepared and pooled. Next, I performed a physical depletion of LIN+ BM cells to 
obtain LIN— cells as described in the Materials and Methods. Results show that after 
the depletion protocol, there was a loss of most of the granulocytes which have a 
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high side scatter and most of the reticulocytes which have a low forward scatter 
(Figure 3.2A). To ascertain the efficiency of the depletion of LIN+ cells, the frequency 
of residual LIN+ cells after the depletion protocol was determined and the Gr1+ cells 
were the major contaminants (Figure 3.2B). Considering that the physical depletion 
of LIN+ BM cells is not 100% efficient, I further excluded residual LIN+ cells which 
were biotinylated during the depletion step, using streptavidin (Figure 3.2C). 
To identify BM HPC subsets using the classical scheme pioneered by Akashi and 
colleagues (12), LIN— cells were labelled with fluorochrome conjugated monoclonal 
antibodies against CD117, Sca-1, CD16/32 and CD34. The gating strategy involved 
selecting live LIN—cells, excluding doublets, selecting the CD117hi Sca-1—population 
and resolving this population into the MEP, CMP and GMP based on surface 
expression of CD16/32 and CD34 (Figure 3.2D). 7-Amino-Actinomycin D (7AAD) was 
used to distinguish live from dead cells in all experiments. Consistent with published 
works (12,68,102), the use of CD16/32 and CD34 only poorly resolved these 
populations and would present enormous difficulties in sorting these populations at 
a high purity, thus justifying the need to identify novel marker combinations. 
The surface expression of CD27 on cells within the HPC compartment is associated 
with myeloid potential while the lack thereof is associated with 
megakaryocytic/erythroid potential (68). Using this marker, I would be able to 
segregate the MEPs which are CD27— from the myeloid progenitors (CMP and GMP) 
which are CD27+. I incorporated as second marker the SLAM family member CD150, 
to resolve the heterogeneity in the megakaryocytic/erythroid pool, which had been 
identified by Pronk et al. using CD150 and CD105 (19). Next, I determined the CD150 
and CD27 surface expression in classically defined MEP, CMP and GMP. LIN— cells 
were labelled with fluorochrome conjugated monoclonal antibodies against CD117, 
Sca-1, CD16/32, CD34, CD150 and CD27. Anti-CD150 and Anti-CD27 cell labelling 
revealed heterogeneity in the classically defined MEP and CMP. Both progenitors had 
CD150— and CD150+ subpopulations, in addition, the MEP had CD27— and CD27Int 
subpopulations while the CMP had CD27+ and CD27int subpopulations. The GMP 
remained homogenous and was CD150— and CD27+ (Figure 3.2E). In contrast to the 
CD150— CMP and GMP that express CD27, the CD150—MEP did not express CD27. 
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Interestingly, both the CD150+ fractions of the MEP and CMP were CD27int and made 
up 15.5 ± 2.1% and 31.8 ± 5.3% of the cells respectively. 
I super-imposed these populations derived from the CD150/CD27 break down of the 
MEP, CMP and GMP, and identified three distinct populations which were 
CD150— CD27— (megakaryocytic/erythroid), CD150—CD27+ (myeloid) and a unique 
population that was CD150+CD27int (Figure 3.2F). CD150 is expressed by cells higher 
up the haematopoietic pathway such as the LTHSCs and MPP2 which is an erythroid 
biased multipotent progenitor (15), and its expression in subpopulations of MEP and 
CMP suggest that these subpopulations might be more primitive than their respective 
CD150— fractions and might constitute a population of their own. 
To further confirm phenotypically, the identity of these populations resolved using the 
novel marker combination of CD150 and CD27, I incorporated an additional marker 
CD135. also known as foetal liver kinase 2 (FLK2) or fms-like tyrosine kinase 3 (FLT3). 
CD135 is not expressed on MEPs and HSCs but is present on CMPs, GMPs and 
MPP4 (126). LIN— cells were labelled with fluorochrome conjugated monoclonal 
antibodies against CD117, Sca-1, CD150, CD27 and CD135. Within the HPC pool, 
the CD150—CD27— and CD150+ CD27int populations were both CD135—, whereas 
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Figure 3.2 CD150, CD27 and CD135 surface expression reveals phenotypic 
heterogeneity of early BM haematopoietic progenitor cells  
(A-B) BM cells isolated from femur and tibia of WT mice were physically depleted of LIN+ cells by 
magnetic activated cell sorting (MACS), and the frequency of residual LIN+ cells was determined. 
Representative FACS plots illustrating (A) the cell size (FSC-A) and granularity (SSC-A) of BM cells, 
before and after depletion of LIN+ cells. (B)  the frequency of residual CD3ε+ CD8α+, CD11b+, CD11c+, 
CD19+, B220+, Gr1+, NK1.1+ and Ter119+ cells after physical depletion protocol. Monoclonal antibodies 
against lineage antigens were conjugated to FITC. (C-G) Residual LIN+ cells were electronically 
excluded using streptavidin and LIN— cells were labelled with fluorochrome conjugated monoclonal 
antibodies against CD117, Sca-1, CD16/32, CD34, CD150, CD27 and CD135. 7-Aminoactinomycin D 
(7AAD) was used to exclude dead cells. (C) Representative FACS plots showing the frequency of LIN— 
cells and residual Gr1+ cells after electronic exclusion of LIN+ cells by streptavidin. Of note is the 
substantial reduction in frequency of Gr1+ cells (D) Gating strategy for the identification of HPC 
subsets; MEP, CMP and GMP. (E) CD150 and CD27 surface expression in MEP, CMP and GMP (F) 
Representative FACS plot illustrating how the classically defined CMP, MEP, and GMP align, when 
stained with CD150 and CD27. (G) CD135 surface expression in CD150—CD27—, CD150+CD27int and 
CD150—CD27+ HPC subsets. 
(A-G) Data represents three individual experiments with similar results using three  mice in each 
experiment; n=9. 
3.3 Analysis of the functional potential of CD150+ CD27int 
and CD150—CD27— HPCs  
Having used a novel phenotypic approach to identify a unique population within the 
HPC pool that is, the CD150+ CD27int HPC, I determined Its functional potential 
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in vitro. Based on the work of Pronk and colleagues (19), I hypothesised that this 
population might contain the Pre-MEP owing to the surface expression of CD150, 
and the absence of CD135 surface expression. The functional potential of the 
CD150— CD27— HPC was also determined in-vitro to confirm that this population is 
a bona fide MEP. 
Using pooled BM from eight naïve female C57BL/6 mice, both populations were 
isolated by fluorescence activated cell sorting (FACS) to a purity greater than 95% 
(Figure 3.3 A-C). After cell sorting, 1 x 104 CD150+ CD27int and CD150— CD27—HPCs 
were seeded into the wells of a 24-well flat-bottomed plate containing erythroid 
differentiation medium (described in Materials and Methods). 
After 36 hours in culture, the CD150+ CD27int population lost surface expression of 
both CD150 and CD27 to acquire a MEP-like phenotype (Figure 3.4A and Table 3.1) 
indicating that this population contains the Pre-MEP. The CD150— CD27— population 
acquired the erythroid marker Ter119 after 6 days in culture (Figure 3.4B and Table 



































































































Figure 3.3 Analysis of CD150+ CD27int and CD150— CD27—HPC subsets before 
and after FACS purification 
BM from eight naive female C57BL/6 mice were pooled, LIN+ cells were physically depleted and both 
CD150+CD27int and CD150—CD27— HPC subsets were FACS purified. (A) Pre-sort gating strategy for 
CD150+CD27int and CD150—CD27— HPC subsets. Post-sort analysis show that both CD150+CD27int 
and CD150—CD27— HPC subsets were sorted to over 95% purity in (B) and (C) respectively. 
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Figure 3.4 Lineage commitment fate of CD150+ CD27int and CD150— CD27— 
HPC subsets in vitro 
(A) CD150+ CD27int HPC subset were purified by FACS from steady state LIN— BM cells and stained 
for surface expression of CD150 and CD27 before and at several time points after culture under 
erythroid conditions. CD150+ CD27int HPC exhibit erythroid potential and differentiate to CD150—
CD27—HPC in vitro. Data represents three independent experiments, using eight female C57BL/6 mice 
in each experiment, n=24. (B) CD150— CD27— HPC subset were purified by FACS from steady state 
LIN— BM cells and stained for surface expression of Ter119 before (Post sort, blue line shows 
unstained control) and at several time points after culture under erythroid conditions. CD150+ CD27int 
HPC is a direct precursor of CD150— CD27— HPC and both populations exhibit erythroid potential with 
the latter differentiating to Ter119+ erythroblasts in vitro. (A and B) Data represents three independent 
experiments, using eight female C57BL/6 mice in each experiment, n=24. 
Table 3.1 CD150+ CD27int HPC is a direct precursor of CD150—CD27—HPC 
Time 
(hours) 
CD150+ CD27int HPC 
(mean ± SD) 
CD150— CD27—HPC 
(mean ± SD) 
0 98.3 ± 0.5 0 
12 66.0 ± 3.6 23 ± 3.1 
24 43.3 ± 3.5 42 ± 7.2 
36 15.3 ± 2.5 76.6 ± 7 
Ter119 APC 
95 72 57 18 0 
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Note: Values represent the frequency of CD150+ CD27int and CD150—CD27— HPC 
subsets at several time-points in culture under erythroid conditions. 
 




(mean ± SD) 
0 0 
12 16.3 ± 1.5 
24 52.6 ± 4.5 
48 68.0 ± 3.6 
144 90.6 ± 3.8 
Note: Values represent the frequency of Ter119+ cells arising from the differentiation 
of CD150—CD27—HPC under erythroid conditions. 
 
3.4 Defining erythroid precursors in the adult BM in steady 
state 
Previous studies identifying erythroid precursors involved staining the whole BM 
using two markers CD71 and Ter-119 without eliminating other BM subsets which 
are prone to possible variation in their numbers in the BM as part of the circadian 
rhythm of the neuro-endocrine system. This could impinge on the calculated 
frequencies and absolute numbers of erythroid precursors under homeostatic 
condition and in infection-induced state. I refined the identification scheme to be less 
dependent on possible variations of other BM subsets. 
To resolve erythroid precursors in steady state, pooled BM cells from two or three 
female C57BL/6 mice were first physically depleted of CD3ε+, CD11b+, CD19+ and 
Gr1+ cells by magnetic activated cell sorting (MACS) using biotinylated monoclonal 
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antibodies against these surface markers, then labelled with fluorochrome 
conjugated anti-CD71, anti-Ter119 and streptavidin. 7AAD was used to distinguish 
live from dead cells. The gating strategy for identifying erythroid precursors involved 
electronically excluding residual CD3ε+, CD11b+, CD19+ and Gr1+ BM cells, dead cells 
and doublets. The cells were first resolved based on surface expression of CD71 and 
Ter119 with the proerythroblasts identified as CD71+ Ter119int cells. The Ter119+ cells 
were then resolved into basophilic, polychromatic and orthochromatic erythroblasts 
based on surface expression of CD71 and cell size in accordance with the gating 
strategy employed by Chen and colleagues (33). I observed a gradual decrease in 
CD71 expression and cell size from the basophilic to the orthochromatic erythroblast 
(Figure 3.5A). Using this combination of markers and gating strategy, I observed that 
the steady state physiological progression of terminal erythroblast maturation follows 



















































I:   Proerythroblast (CD71+Ter119int) 
II:  Basophilic erythroblast (CD71+Ter119+FSC-Ahi) 
III: Polychromatic erythroblast (CD71+Ter119+FSC-Aint) 
IV: Orthochromatic erythroblast (CD71+Ter119+FSC-Alo) 
 











Figure 3.5 Characterisation of BM erythroid precursors in steady state 
BM cells were depleted of T cells, monocytes, B cells and granulocytes by MACS using biotinylated 
monoclonal antibodies against CD3ε, CD11b, CD19 and Gr1, then stained with 
Streptavidin-PerCP-Cy5.5, CD71-PE and Ter119-APC. 7AAD was used to exclude dead cells. (A) 
Gating strategy for the identification of erythroid precursors. I, II, III and IV represent the 
proerythroblasts, basophilic erythroblasts, polychromatic erythroblasts and orthochromatic 
erythroblasts respectively. (B) Bar chart showing the mean frequency of erythroid precursors as a 
percentage of all Ter119+ cells. Among all Ter-119+ BM cells, proerythroblasts, basophilic 
erythroblasts, polychromatic erythroblasts and orthochromatic erythroblasts had a frequency of 3.5 ± 
0.1%, 7.1 ± 0.5%, 15.9 ± 1.2% and 34.4 ± 2.5%, a ratio of 1:2:4:8 demonstrating the expected 
doubling of cell number with each successive mitosis. 
Data represents six individual experiments using two to three mice per experiment. Bars represent 
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3.5 Quantitation of haematopoietic progenitor cells and 
erythroid precursors in steady state. 
To determine the absolute number of HPC subsets and erythroid precursors, I opted 
for a different approach. Rather than physically depleting LIN+ cells I electronically 
excluded all LIN+ cells as described in the Materials and Methods. 
Some of the merits of electronic exclusion over physical depletion of LIN+ cells are 
reproducibility, reliability and ease of processing under pathological conditions. Also, 
at the start of sample acquisition, all the cell types in the BM are present at the normal 
frequency in steady state, calculated gate frequencies are a fraction of the entire BM 
and can be used to determine the absolute number of cells per femur/tibia pair. 
Furthermore, erythroid precursors have ferrous iron (Fe2+) in the haem complex which 
might result in these cells being trapped in the magnetic column and hamper 
recovery. 
To determine the absolute number of CD150— CD27—, CD150—CD27+ and 
CD150+CD27int HPC subsets, first I prepared single-cell suspensions of BM obtained 
from femur and tibia pair of each mouse and determined the cellularity. Next, I 
labelled the BM cells with FITC conjugated monoclonal antibodies against lineage 
markers, CD117, Sca-1, CD150 and CD27.  
After excluding dead cells, doublets and LIN+ cells, the LIN— cells had a frequency of 
1.2 ± 0.3% of total BM cells (Figure 3.6A) and a mean absolute number per femur/tibia 
pair of 5.1 x 105 ± 2.4 x 104 (Figure 3.6B) The LIN— cells were further resolved on the 
basis of CD117 and Sca-1 to identify the HPC pool. Within the HPC pool, I observed 
in steady state that the CD150—CD27+ HPC subset was the most abundant, while the 
CD150+CD27int HPCs were the least abundant (Figure 3.6B) 
To determine the absolute number of erythroid precursors, I prepared single-cell 
suspensions of BM obtained from femur and tibia pair of each mouse, then 
determined the cellularity. After excluding T cells, monocytes, B cells and 
granulocytes, live single cells were resolved based on surface expression of CD71 
and Ter119 as previously described in Figure 3.5A. Using the calculated frequencies 
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and BM cellularity, the absolute number of each erythroid precursor per femur/tibia 
pair was determined. In steady state, the mean BM cellularity was 
4.6 x 107 ± 2.4 x 106, while the mean absolute number of proerythroblasts, basophilic 
erythroblasts, polychromatic erythroblasts and orthochromatic erythroblasts per 
femur/tibia pair was 7.2 x 105 ± 1.8 x 105, 1.7 x106 ± 2.5 x 105, 3.9 x 106 ± 2.1 x 105 












Figure 3.6 Quantitation of erythroid progenitors and precursors in murine BM 
in steady state 
(A) Representative FACS plots illustrating the frequency of LIN— cells per femur/tibia pair, in which 
LIN+ cells have been electronically excluded. Data represents six experiments using two to three 
female mice in each experiment, n =16. (B)  Absolute number per femur tibia pair of LIN— cells, HPC, 
CD150— CD27—, CD150+ CD27int and CD150—CD27+HPC subsets. (C) Absolute number per femur tibia 
pair of all BM cells, proerythroblasts, basophilic erythroblasts, polychromatic erythroblasts, 
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independent experiments using two to three female mice in each experiment. Values represent 
mean ± SEM, n=16 mice. 
3.6 Discussion 
The BM under homeostatic conditions is the only site of erythropoiesis in mice and 
humans. Hence, the accurate enumeration of erythroid populations with a high 
degree of accuracy is a pre-requisite for the study of disordered erythropoiesis. 
Furthermore, it is the basis of the prospective isolation of developmental-ordered 
subpopulations for further analysis. 
For almost two decades, the surface markers CD16/32 and CD34 have been used to 
identify the three main subpopulations within the HPC pool; MEP, CMP and GMP. 
This marker combination only poorly resolves these HPC subsets and result in low 
purity of FACS sorted cells. Data from our lab using this marker combination, showed 
considerable contamination of FACS purified MEPs by CMPs (68). Furthermore, the 
use of CD16/32 and CD34 does not permit the identification of a recently described 
population within the HPC pool the Pre-MEP. There is therefore a need for novel 
marker combinations that can identify these HPC subsets at a greater resolution and 
high purity. 
I sought surface markers that were stable during infection and based on published 
works (19,68)    , I came up with two surface markers namely CD150 and CD27. By 
substituting CD16/32 and CD34 for CD150 and CD27, I was able to show 
heterogeneity within the HPC pool, similar to findings by Pronk and colleagues (19). 
Furthermore, I was able to identify a novel population within the HPC pool which is 
CD150+CD27int. Phenotypic profiling revealed that both the CD150+CD27int and 
CD150—CD27— lacked surface expression of CD135 whereas majority of the CD150—
CD27+ cells expressed CD135 on their surface. CD135 promotes the survival and 
proliferation of myeloid progenitors (127,128) and its expression on the CD27+cells, 
further confirms that CD27 is a marker for myeloid commitment in the HPC pool. The 
absence of CD135 surface expression on CD150+ CD27int HPC subset clearly argues 
that this population is biased towards an erythroid lineage fate and might contain the 
pre-MEP. After in vitro functional assays, I demonstrated that the CD150—CD27— HPC 
  CHAPTER 3 
 52 
subset is the MEP analogue while the CD150+CD27int HPC subset is the Pre-MEP 
analogue. The CD150+CD27int HPC subset committed to an erythroid fate under 
erythroid conditions, nevertheless, it remains to be seen if this recently described 
population exhibits some degree of lineage plasticity and is able to commit to a 
myeloid fate under myeloid conditions. 
The use of CD71, Ter119 and cell size to identify erythroid precursors in BM was able 
to recapitulate the physiological progression of normal murine terminal erythroid 
differentiation at a ratio of 1:2:4:8. Any deviation from this ratio might be indicative of 
disordered erythropoiesis and could provide important leads for mechanistic studies 
defining stage-specific defects in erythroid maturation in inherited and acquired red 
cell disorders. In previous studies, the use of the surface markers CD71 and Ter119 
alone to identify erythroid precursors in the BM had failed to achieve the expected 
ratio of 1:2:4:8 and this might have been due to the different gating strategies 
employed in the identification of these cells, as well as the failure to incorporate cell 
size in distinguishing the various stages of erythroblast maturation. 
Similar to a previous study by Chen and colleagues (33), I observed a progressive 
decrease in cell size and surface expression of transferrin receptor as the erythroid 
precursors differentiated from the basophilic erythroblast to orthochromatic 
erythroblasts Furthermore it has been reported that the orthochromatic erythroblasts 
are the same size as mature erythrocytes (33,129) and this was my observation when 
I identified these populations. While the mature erythrocytes express Ter119 but do 
not express CD71, the orthochromatic erythroblasts express both Ter119 and CD71. 
In addition, immature reticulocytes express CD71 (130,131) and cluster in the same 
gate as the orthochromatic erythroblasts (33). An inherent problem in using CD71 and 
Ter119 to identify erythroid precursors, is that this marker combination does not 
permit the orthochromatic erythroblasts to be distinguished from immature 
reticulocytes. 
in contrast to the mapping of the myeloid population in detail, the early erythroid 
subsets have been quite neglected. I have demonstrated an unpublished method for 
the identification and isolation of primitive erythroid progenitors at high purity. In this 
study, I defined erythroid progenitors within the HPC pool namely, the MEP as LIN— 
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CD117hi Sca-1—CD150—CD27—CD135— and the Pre-MEP as LIN— CD117hi Sca-1—
CD150+CD27intCD135—. Although the labelling of HPC with anti-CD150 and 
anti-CD27 fluorochrome conjugated monoclonal antibodies is sufficient to resolve the 
distinct erythroid progenitors within the HPC pool, it does not resolve the myeloid 
progenitors into distinct CMP and GMP with both progenitor populations clustering 
in the same gate, that is the CD150—CD27+ gate. Hence, I defined myeloid 
progenitors (CMP and GMP) as LIN— CD117hi Sca-1—CD150—CD27+. This limitation 
should not impair studies of disordered erythropoiesis, nevertheless, in studies of 
myelopoiesis, anti-CD16/32 fluorochrome conjugated monoclonal antibody could be 
incorporated to distinguish CMP which are CD16/32lo from GMP which are CD16/32hi. 
The use of CD150/CD27 marker combination to resolve HPC subsets is a significant  
contribution to the field and provides better resolution of erythroid progenitors (MEP 
and Pre-MEP), higher purity of FACS sorted cells and clearly segregates myeloid from 
erythroid progenitors. A notable contribution of this study is that the ability to isolate 
primitive erythroid progenitors in large quantity and high purity should enable a 
detailed molecular characterisation of these populations and provide useful insights 
into the mechanisms of erythropoiesis. The purified erythroid cells might also be 
useful for screening drugs that would specifically target distinct erythroid stages 
which could lead to novel therapeutic approaches for patients with disordered 
erythropoiesis. In future studies on the consequence of malaria on erythroid 
development in wild type mice and in mice lacking IFN-γ signalling specifically in 
haematopoietic cells, this marker combination will be used to identify the MEP, 
Pre-MEP and CMP/GMP. I have referred to the MEP, Pre-MEP and CMP/GMP 
population simply as CD27 neg. CD27 int. and CD27 pos. HPC respectively in 
subsequent chapters. 
.




IMPACT OF MALARIA ON ERYTHROID 
DEVELOPMENT 
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4.1 Introduction 
During malaria, the exact stage of erythroid development in the BM, at which 
suppression of erythropoiesis sets in remains unknown. Furthermore, there is at 
present, no study on malaria dyserythropoiesis that has investigated cells with 
erythroid potential but lacking myeloid and lymphoid potential, that are more primitive 
than the BFU-e. Hence, malaria dyserythropoiesis could be due to defective potential 
for erythroid development in HSCs, MPPs or erythroid precursors alone or in 
combination. 
The aetiology of SMA is multifactorial but two main mechanisms stand out, the 
destruction of parasitised and non-parasitised erythrocytes as a result of parasite 
replication and splenic clearance respectively, and the suppression of erythropoiesis 
in the BM. These mechanisms have been implicated in both human and mouse 
malaria models (98). Several studies have reported that this suppression of BM 
erythropoiesis during malaria correlates with the degree of parasitaemia(132). I aimed 
to determine how the erythroid progenitors and precursors defined in the preceding 
chapter are impacted by experimental malaria and whether the suppression of 
erythroid development in the BM is dependent on the degree of parasitaemia. 
To determine if BM suppression during malaria correlates with the degree of 
parasitaemia, I used three different models of infection that differ in virulence, parasite 
burden at peak parasitaemia and the immune response elicited, namely the serial 
blood passage (SBP), the mosquito transmission (MT) and the sporozoite inoculation 
(SI) models. I established experimental malaria in mice using the rodent malaria 
parasite Plasmodium chabaudi chabaudi AS (Pcc AS). Pcc AS establishes 
synchronous, chronic and recrudescing blood-stage infections in rodents, and 
exhibits many characteristics associated with the pathogenesis of human malaria, 
such as rosetting, sequestration and antigenic variation (97). Some of the features of 
Pcc AS malaria such as severe anaemia, splenomegaly and BM suppression, make 
it a very useful model for studying abnormal erythroid development. To dissect the 
exact stage of erythroid development that BM suppression sets in, I investigated 
populations with a capacity for erythroid lineage commitment that are more primitive 
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than the BFU-e namely the MEP and Pre-MEP. The investigation of the impact of 
malaria on the most primitive erythroid progenitors is the first of its kind as the MEP 
and pre-MEP were only able to be identified by flow cytometry in the recent years. 
In addition, I investigated the impact of malaria on the latter stages of erythropoiesis, 
that is, the proerythroblast to the orthochromatic erythroblast stages. Rather than 
analysing this latter stage as a whole (CD71+ Ter119+ cells), I have analysed each 
distinct population at this stage. I also expanded my investigation to include an 
additional site of erythropoiesis, the spleen. 
Extramedullary haematopoiesis in the spleen during malaria has been reported in 
several studies (68), the architecture of the spleen (surrounded by a capsule made up 
of elastic fibres which can stretch up to 1.5 times their length) as opposed to the BM, 
permits its expansion during infection, providing adequate room for the influx and 
proliferation of progenitors (133). I investigated whether the reported increase in the 
number of erythroid progenitors in the spleen during malaria (134) results in an 
increased splenic erythroid output. 
4.2 Impact of acute malaria infection on BM and splenic 
cellularity  
To set up experimental malaria, female C57BL/6 mice were administered an 
intraperitoneal injection of 105 parasitised erythrocytes. These parasitised 
erythrocytes were obtained from donor C57BL/6 mice that were infected with  serially 
blood passaged Pcc AS, exposed to bites of Pcc AS infected female Anopheles 
stephensi or injected with Pcc AS sporozoites, for the serial blood passage, mosquito 
transmission and sporozoite inoculation models of infection respectively. These 
infection models have been discussed in detail in the Materials and Methods. Naïve 
litter-mates were used as controls. 
Peripheral parasitaemia was monitored by thin blood smear throughout acute 
infection. In the SBP model, there was a rapid increase in parasite density, 
reaching >20% at day 7 post-infection, while parasite growth rate was much slower 
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in the MT and SI models, with parasitaemia that did not exceed 1% at the time-points 
sampled (Figure 4.1A). 
At day 5 and 7 post-infection, BM from naïve and infected Pcc AS mice were obtained 
and the cellularity was determined (Figure 4.1B). Changes in the BM cellularity, which 
considers the absolute number all the cells in the BM, as well as changes in the 
absolute number of BM LIN— cells resulting in a hyper-proliferative or 
hypo-proliferative state are indicative of potential pathology. At day 5 post-infection 
there was no difference in BM cellularity between naïve and infected mice while at 
day 7 post-infection, I observed a significant contraction in the BM cellularity which 
coincided with the peak parasitaemia at the time points sampled. This contraction in 
BM cellularity reflected in the number of LIN— BM cells. At day 5 post-infection, a 
significant reduction in number of LIN— BM cells had already set in, with an even 
greater reduction at day 7 post-infection (Figure 4.1C). Spleens were harvested from 
naïve and infected mice, and splenic cellularity was determined. In striking contrast 
to my observation in the BM, there was a significant increase in splenic cellularity at 
day 7 post-infection (Figure 4.1D). The spleens from infected mice were also larger 
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Figure 4.1 Contraction of BM cellularity and increase in splenic cellularity 
during acute malaria infection 
Female wildtype C57BL/6 mice were infected with 105 Pcc AS parasitised erythrocytes and naïve 
littermates were used as controls (A) Geometric mean parasitaemia in three malaria models of infection 
(SBP, MT and SI), the error bars indicate 95% confidence intervals. B-F show results for SBP model 
of infection. (B) Absolute number per femur/tibia pair of BM cells in naïve and infected mice at day 5 
and 7 post-infection. Of note is the significant reduction in BM cellularity in infected mice at day 7 
post-infection. (C) Contraction of BM LIN— cells during acute Pcc AS infection. (D) Absolute number 
of cells per spleen in naïve and infected mice. (E) Image showing the spleens from naive and infected 
mice at day 7 post-infection. (F) Box and whisker plot showing mass of spleens from naive and 
infected mice at day 7 post-infection. 
(A – F) Data shown are from two independent experiments. (B, C, D, F) Values represent mean ± SEM, 
n = 10 mice for SBP and SI models and n = 6 mice for MT model and naïve controls. Significance was 
calculated using the Student’s t-test. Asterisks represent statistically significant differences (ns: not 
significant; *: P<0.05; **: P<0.01; ***: P<0.001; **** :P<0.0001). 
4.3 Changes in BM haematopoietic progenitor cell pool in 
BM and spleens of mice with P. c. chabaudi AS malaria 
HSCs and multipotent progenitors are characterised in steady state by high 
expression of c-Kit and Sca-1. In contrast, HPCs are negative for Sca-1 but still retain 
high levels of c-Kit at the surface (68). During malaria and in systemic infections, there 
is a release of proinflammatory cytokines, in particular IFN-γ which directly increases 
Ly6a transcription and causes upregulation of Sca-1 on HPCs resulting in an 
amalgamation of the HPC pool and the LSK pool (68). The amalgamation of the LSK 
and HPC pool has been well documented in different experimental 
conditions.(75,102,135,136). Using the SBP, MT and SI models of infection, I 
investigated if these changes could be observed in the HPC pool which constitutes 
the most abundant cell pool within the LIN— fraction of the BM and is made up of the 
MEP, Pre-MEP, CMP and GMP. 
At day 5 and day 7 post-infection, BM from naïve and Pcc AS infected mice were 
obtained and the LIN+ cells were excluded using lineage markers as described in 
Chapter 3 and also in the Materials and Method. The resulting LIN— cells were labelled 
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with fluorochrome conjugated monoclonal antibodies against CD117 and Sca-1 to 
identify the HPC and LSK compartments.  
In agreement with published work by Belyaev and colleagues (68), At day 7 
post-infection, the HPC compartment showed an upregulation of Sca-1 expression 
on virtually all cells in the SBP, MT and SI models of infection (Figure 4.2 A-C). This 
upregulation of Sca-1 had already set in at day 5 in both the SBP and SI models. The 
upregulation of Sca-1 has been shown to be induced by proinflammatory cytokines 
namely IFN-γ (137), and my findings suggest the presence of systemic IFN-γ acting 
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Figure 4.2 Infection induced upregulation of Sca-1 on HPCs 
LIN— cells from naïve controls and Pcc AS infected mice at day 5 and 7 post-infection were stained 
with CD117 and Sca-1. Sca-1 is upregulated on BM HPCs in (A) SBP (B) MT (C) SI models of infection. 
Data represents results from two independent experiments, n=10 mice per time point (A) or one 
experiment, n=5 mice per time point (B and C). 
The infection induced upregulation of Sca-1 on HPCs results in the amalgamation of 
the HPC and LSK pools creating an operational problem of how to identify the 
Pre-MEP, MEP, CMP and GMP during malaria, which in steady state lack surface 
expression of Sca-1. To address this, the HPC gate was extended to include both 
CD117hi Sca1— and CD117hi Sca-1+ cells (Figure 4.3), these cells were further resolved 
using CD150 and CD27 to identify the Pre-MEP, MEP, CMP and GMP analogues as 
shown in Figure 4.3. The functional names MEP, Pre-MEP, CMP and GMP were 
ascribed on the basis that in steady state these populations are Sca-1—, hence, 
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Figure 4.3. Identification of erythroid and myeloid progenitors during malaria 
Gating strategy for identifying erythroid and myeloid progenitors during malaria. LIN— BM cells from 
naïve controls and Pcc AS infected mice at day 5 post-infection were stained with fluorochrome 
conjugated monoclonal antibodies against CD117, Sca-1, CD150 and CD27. CD117hi LIN— cells are 
resolved into MEP (CD150—CD27—), Pre-MEP (CD150+CD27int) and CMP/GMP (CD150—CD27+) 
analogues. 
To determine the impact of malaria on erythroid progenitors, LIN— BM cells from naïve 
and Pcc AS infected mice at day 5 and day 7 post-infection were stained with 
monoclonal antibodies against CD117, Sca-1, CD150 and CD27. In the SBP model, 
I observed at days 5 and 7 post-infection, a significant increase in the frequency and 
absolute number of MEP analogue, a significant decrease in the number of 
CMP/GMP analogue but no significant difference in the Pre-MEP analogue 
(Figure 4.4A-D) Previous work in our lab demonstrated that this contraction in BM 
myelopoiesis during malaria is as a result of the mobilisation of the myeloid 
progenitors to the spleen (68). Similar observations were made in the MT and SI 
model (Figure 4.4E-H), but unique to the MT model, was a significant decrease in the 
Pre-MEP analogue at day 7 post-infection which might relate to differences in elicited 
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Figure 4.4 Infection induced expansion of erythroid progenitors and 
contraction of myeloid progenitors in three malaria models 
Representative FACS Plot illustrating the frequency of MEP, Pre-MEP and CMP/GMP analogues in 
the BM of naive and Pcc AS infected mice in (A) SBP model at day 5 post infection, and at day 7 
post-infection in (C) SBP model (E) MT model and (G) SI model. Absolute number per femur/tibia pair 
of MEP (CD27 neg), Pre-MEP (CD27int) and CMP/GMP (CD27 pos) analogues in naive and Pcc AS 
infected mice at (B) day 5 post infection in SBP model, and at day 7 post-infection in (D) SBP model 
(F) MT model and (H) SI model. (A-D) Data represents results from two independent experiments, 
values represent mean ± SEM, n=10 Pcc AS infected mice per time point and n= 6 naïve mice per time 
point. (E-F) Data represents results from one experiment, values represent mean ± SD, n=5 Pcc AS 
infected mice per time point and n= 3 naïve mice per time point. Significance was calculated using the 
Student’s t-test. Asterisks represent statistically significant differences (ns: not significant; *: P<0.05; 
**: P<0.01). 
It has been demonstrated by Belyaev et al. (68) that during acute malaria infection 
with P. chabaudi, the myeloid progenitors which are in the same developmental 
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and Sca-1, are mobilised to the spleen which results in an increase in the number of 
myeloid progenitors in the spleen. I investigated if the same might be true for the 
erythroid progenitors. 
C57BL/6 mice were infected with 105 Pcc AS parasitised erythrocytes using the SBP 
model of infection. At day 7 post-infection, spleens were obtained from infected mice 
and naïve controls, and LIN+ cells were electronically excluded as described in 
Chapter 3 and Materials and Methods. Similar to the BM, LIN— splenocytes were 
resolved using monoclonal antibodies against CD150, Sca-1, CD150 and CD27 to 
identify the MEP, Pre-MEP and CMP/GMP analogues in the spleen. 
At day 7 post-infection, I observed an increase in the frequency of the MEP analogue, 
but a contraction in the frequency of Pre-MEP and CMP/GMP analogues (Figure 
4.5A). Despite the contraction in frequency, the considerable increase in splenic 
cellularity during Pcc AS malaria, resulted in a significant increase in the absolute 
number per spleen of all erythroid and myeloid progenitors. (Figure 4.5B). I observed 
an 18-fold increase in the absolute number of the MEP analogue which was surprising 
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Figure 4.5 Infection induced increase in number of MEP analogue in spleen of 
mice with P. c. chabaudi AS malaria 
(A) FACS plots illustrating the frequency of MEP, Pre-MEP and CMP/GMP analogues in the spleen of 
naive and Pcc AS infected mice at day 7 post-infection using the SBP model of infection. (B) Absolute 
number of MEP (CD27 neg), Pre-MEP (CD27int) and CMP/GMP (CD27 pos) analogues per spleen of 
naive and Pcc AS infected mice at  day 7 post-infection using the SBP model. (A and B) Data 
represents results from two independent experiments, values represent mean ± SEM, n=10 Pcc AS 
infected mice per time point and n= 6 naïve mice per time point. Asterisks represent statistically 
significant differences (ns: not significant; **: P<0.01). 
4.4 Changes in erythroid precursors in BM and spleen of 
mice with P. chabaudi malaria  
The suppression of erythropoiesis during malaria, in humans and in mouse models 
has been well documented. Low reticulocytosis, indicative of reduced RBC output is 
an important feature of SMA. This low reticulocytosis during malaria is associated 
with suppressed proliferation, differentiation and maturation of erythroid 
precursors (138). To further dissect the impact of malaria on erythroid development, 
I determined if the observed increase in the MEP analogue in spleen and BM during 
malaria would reflect in the number of downstream erythroid precursors in both sites. 
C57BL/6 mice were infected with 105 Pcc AS parasitised erythrocytes using the SBP, 
MT and SI models of infection. At day 5 (SBP only) and day 7 post-infection, BM from 
femur and tibia pair of naïve and infected mice was obtained and the frequency and 
absolute number of erythroid precursors per femur/tibia pair was determined as 
described in Chapter 3. 
To the best of my knowledge, changes in the expression of surface markers used to 
identify erythroid precursors has not been reported during infection, hence, during 
experimental malaria, these cells were identified using surface markers and gating 
strategy as in steady state. At day 7 post-infection, I observed a significant 
contraction of each erythroid precursor stage regardless of the model of infection 
(Figure 4.6A-F). The frequency of the orthochromatic erythroblasts in infected mice 
was similar to naïve controls in all three models of infection, but the substantial 
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contraction in BM cellularity during infection accounted for the significant decrease 
in this population. The observed increase in the BM MEP analogue during malaria 
failed to reflect in downstream erythroid precursors suggesting impaired 
differentiation and/or the mobilisation of this population to the spleen which might 
account for the 18-fold increase of this population in the spleen. 
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Figure 4.6 Contraction of erythroid precursors in BM of mice infected with 
P. c. chabaudi AS. 
BM cells from naïve controls and Pcc AS infected mice were stained with fluorochrome conjugated 
antibodies against CD3ε, CD11b, CD19, Gr1, CD71, Ter119 and live-dead discriminator 7AAD. Cells 
expressing CD3ε, CD11b, CD19 and Gr1 as well as dead cells and doublets were excluded from 
analysis. FACS plots illustrating the frequency of erythroid precursors in the BM of naive and Pcc AS 
infected mice at day 7 post-infection using the SBP (A), MT (C) and SI (E) models of infection. Absolute 
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number of erythroid precursors per femur/tibia pair in naive and Pcc AS infected mice at day 5 and 7 
post-infection using the SBP (B), and at day 7 post-infection using the  MT (D) and SI (F) models of 
infection. (A,B) Data represents results from two independent experiments, values represent mean ± 
SEM, n=10 Pcc AS infected mice per time point and n= 6 naïve mice per time point. Significance was 
calculated using one-way ANOVA and Tukey multiple comparisons test. (C-F) Data from one 
experiment, values represent mean ± SD, n=5 Pcc AS infected mice per time point and n= 3 naïve 
mice per time point. Significance was calculated using the Student’s t-test. Asterisks represent 
statistically significant differences (ns: not significant; *: P<0.05; **: P<0.01). 
Next, I determined if the infection induced increase in the MEP analogue in the spleen 
would reflect in the number of erythroid precursors in this organ. C57BL/6 mice were 
infected with Pcc AS using the SBP model of infection. At day 7 post-infection, 
spleens from naïve controls and infected mice were obtained and the frequency and 
absolute number of erythroid precursors per spleen was determined in a similar 
manner as in the BM, which has been described in Chapter 3. No change in the 
frequency of proerythroblasts was observed, but a decrease in frequency of 
basophilic, polychromatic and orthochromatic erythroblasts was evident in spleens 
of infected mice (Figure 4.7A). Due to the significant increase in spleen cellularity 
during infection, the decreased frequency of erythroid precursors in infected mice did 
not translate to a decrease in their absolute numbers per spleen. Instead, there was 
a significant increase in the absolute number of proerythroblasts but no significant 
difference in all downstream erythroid precursors (Figure 4.7B). The expansion of 
erythroid progenitors in the BM and spleen which failed to reflect in the number of 





















Figure 4.7 Absence of increased extramedullary erythropoiesis during 
P. chabaudi malaria 
C57BL/6 mice were infected with 105 Pcc AS parasitised erythrocytes using the SBP model of 
infection. Uninfected littermates were used as controls (A) FACS plots illustrating the frequency of 
erythroid precursors in the spleen of naive and infected mice at day 7 post-infection using the SBP 
model of infection. (B) Bar chart showing the absolute number of erythroid precursors per spleen of 
naive and Pcc AS infected mice at day 7 post-infection using the SBP model. Data represents results 
from two independent experiments, values represent mean ± SEM, n=10 Pcc AS infected mice per 
time point and n= 6 naïve mice per time point. Significance was calculated using the Student’s t-test. 
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4.5 Serum levels of proinflammatory cytokines potentially 
mediating dyserythropoiesis 
Following the observation that the block in erythropoiesis during malaria was not 
restricted to the BM but also manifested in the spleen, I focussed on host derived 
factors that could be acting at these two sites to simultaneously block erythropoiesis. 
Two key proinflammatory cytokines namely, IFN-γ and TNF-α have been implicated 
as soluble mediators of dyserythropoiesis during malaria. Due to the challenges in 
measuring accurately the exact acting concentration of the secreted proteins in the 
BM and spleen, I determined the serum concentration of these cytokines before and 
at several time points after infection with Pcc AS by enzyme linked immunosorbent 
assay (ELISA) as described in the Materials and Methods. Prior to infection, IFN-γ 
was undetectable in serum but following infection, there was a  transient spike in 
IFN-γ concentration, peaking at day 5 (Figure 4.8A). In contrast, there was basal levels 
of TNF-α prior to infection, which increased and peaked at day-7 post-infection at 
the time points sampled (Figure 4.8B). These observations suggest that IFN-γ and/or 
TNF-α could be mediating early dyserythropoiesis independently or synergistically. 





Figure 4.8 Kinetics of IFN-γ and TNF-α during P. c. chabaudi AS malaria 
C57BL/6 mice were infected with 105 Pcc AS parasitised erythrocytes using the SBP model of 
infection. Serum concentration of (A) IFN-γ and (B) TNF-α during the course of acute malaria. Data 
represents results from two independent experiments, values represent mean ± SEM, n=10 mice per 
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4.6 Discussion 
SMA is a common life-threatening complication of P. falciparum malaria in young 
children under the age of five years. This severe form of anaemia ensues when the 
accelerated destruction/removal of parasitised and non-parasitised erythrocytes is 
not compensated for by an already suppressed BM. It is known that BM suppression 
is generally present in all cases of P. falciparum malaria (139), nevertheless, there are 
conflicting reports on the role of parasite density in bone marrow suppression. Some 
studies have linked the increased destruction of erythrocytes associated with high 
parasite density to bone marrow inhibition (139,140), Pathak et al. reported that BM 
inhibition correlates with the degree of parasitaemia and can be reversed following 
clearance of peripheral parasitaemia (141), while other researchers have reported that 
bone marrow inhibition manifests after treatment and following parasite clearance 
(142–144).  
In this chapter, I demonstrated that the suppression of erythropoiesis in the BM and 
spleen does not correlate with peripheral parasitaemia but might be driven by host 
derived mediators such as IFN-γ and TNF-α. P. chabaudi infected erythrocytes are 
known to sequester in organs during blood stage infection (97), thus, despite the low 
peripheral parasitaemia in the MT and SI models of infection, the parasite density in 
tissue was not accounted for in all models of infection. This information is vital to 
draw conclusions on the role of parasite density in BM suppression. The contraction 
in BM cellularity during acute malaria could be explained by the mobilisation of 
myeloid progenitors from the BM to the spleen and the block in erythroid 
differentiation. The contraction of LIN— BM cells during acute malaria with Pcc AS is 
in line with previous published work by our lab in which the most pronounced 
contraction of LIN— BM cells was observed at day 7 post-infection (68). This 
contraction of LIN—cells was shown to be dependent on IFN-γ signalling via the 
stroma compartment (68). 
The spleen is a site of extramedullary haematopoiesis during stress and is the main 
organ that generates the immune response to malaria parasite and controls the 
removal of parasitised RBCs (145,146). One of the hallmarks of infection with malaria 
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parasite is splenomegaly, so much so that the spleen size has been used as a tool to 
determine the intensity of malaria transmission in endemic areas (147). It has been 
known for about three decades that during malaria in mouse models there is a 
contraction in the number of BM BFU-e but an increase in splenic BFU-e and CFU-e 
(134), providing evidence of extramedullary erythropoiesis during malaria. Consistent 
with the significant expansion of the MEP analogue in the BM, I observed an even 
greater expansion of the splenic MEP analogue. Further study is required to 
determine if this was as a result of proliferation of native splenic erythroid progenitors 
or the mobilisation of BM erythroid progenitors to the spleen in a similar manner as 
the myeloid progenitors. The mobilisation of myeloid progenitors to the spleen during 
acute malaria with Pcc AS to generate the immune cells necessary to control parasite 
replication has been reported previously by our lab (68) and together with the 
expansion of the MEP analogue contributes to the increased spleen size and 
cellularity observed. 
During Pcc AS malaria, the exact stage at which suppression of erythropoiesis sets in 
is yet to be reported and my results suggest that this suppression could be occurring 
at multiple stages. The contraction of the Pre-MEP in the MT model of infection which 
one could argue better mimics human infection, suggests that suppression of 
erythropoiesis during malaria might set in at stages upstream of the Pre-MEP such 
as the MPP2 and HSCs. Furthermore, it remains unknown if the MEP would exhibit a 
higher proliferative capacity in the absence of mediators of dyserythropoiesis such 
as IFN-γ and TNF-α. 
In humans, it is well established that a decreased number of erythroblasts and 
circulating reticulocytes occur in P. vivax and P. falciparum malaria (95,132,148). In 
murine models, experimental P. berghei infection, resulted in a dramatic decrease in 
the number of erythroblasts as early as 24 hours post-infection (149). The 
suppression of erythropoiesis during malaria could be due to a complex mechanism 
that involves both the increased destruction of erythroblasts and a decreased rate of 
proliferation of these cells in the BM. 
A draw-back of some of these studies is that the gating strategy for identifying the 
erythroblasts are not shown while in studies where they are shown, earlier gating 
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strategies were used. A recent study of the suppression of erythropoiesis in murine 
models reported an increase in the frequency of splenic erythroblasts in mice infected 
with either P. chabaudi or P.  berghei in comparison to naive controls. However, this 
study used either CD71 or Ter119 to identify erythroblasts but not in combination, as 
such, the Ter119+ splenocytes were not entirely erythroblasts but included 
reticulocytes and RBCs while the CD71+ cells could have been any proliferating cell 
in the spleen (150).  
Using a gating strategy that permits the identification of all four erythroblast 
populations, namely the proerythroblast, basophilic erythroblast, polychromatic 
erythroblast and orthochromatic erythroblast, I observed that the 1:2:4:8 ratio of 
erythroblast maturation observed in steady state was perturbed during malaria. 
Furthermore, I observed in the BM, a similar degree of contraction in the number of  
erythroid precursors in all three models of infection. In comparison to the BM, the 
suppression of erythroid development was much greater in the spleen. During the 
immune response to malaria, the spleen is the main anatomical site in which immune 
cells are brought into close proximity and interact with foreign malarial antigens, as 
such, it is expected that the highest concentration of proinflammatory cytokines such 
as IFN-γ secreted by immune cells particularly the CD4+ T-cells would be in the 
spleen. This would account for the considerable suppression of erythropoiesis at this 
site. These observations clearly argue in favour of pro-inflammatory cytokines in 
mediating suppression of erythropoiesis during malaria.  
Based on the kinetics of IFN-γ and TNF-α in serum during malaria, I was unable to 
deduce which of these pro-inflammatory cytokines might be mediating 
dyserythropoiesis. Cytokines are potent even at extremely low concentrations and 
despite IFN-γ peaking earlier than TNF-α in the SBP model of infection, the 
concentration of TNF-α even at day 4 post-infection could have been responsible for 
this inhibition of BM erythropoiesis. To dissect this further I established experimental 
malaria in genetic knock out mice incapable of IFN-γ signalling specifically in 
haematopoietic cells. This is discussed in the next chapter. The SBP model of 
infection alone was used in further studies. 
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4.7 Conclusion 
I set out to investigate the impact of malaria on erythropoiesis and made some key 
findings. One of these findings is similar to what has been observed in some human 
studies that BM suppression can occur even in the absence of microscopically 
detectable or very low parasitaemia. This suggests that the suppression of erythroid 
development is independent of peripheral parasite density but is most likely due to a 
dysregulated immune response. To further investigate the role of IFN-γ, I have utilised 
a novel mouse strain lacking IFN-γ signalling in only haematopoietic cells (discussed 
in chapter 5). 
Based on this data and work that has been published by our laboratory on the impact 
of malaria on the BFU-e and CFU-e (67), all stages downstream of the MEP analogue 
are clearly impacted by malaria. Despite the expansion of the MEP analogue which 
suggests some degree of erythroid response to malaria, one cannot exclude the 
possibility that in malaria this population has a higher proliferation index and/or 
remains longer in this development stage. However, my results identify this 
population, upstream of the mature erythrocyte, as stable in all three mouse models 
of malaria.  
Contraction of the pre-MEP was only evident in the MT model, which is most likely 
due to the peculiarities of the models in that, they differ in key elements such as 
parasitaemia, virulence, pro-inflammatory cytokine induction and immune response 
elicited. 
In summary, at early time points in malaria, there is an infection-induced suppression 
of erythroid development in the BM and spleen which is independent of the degree 
of peripheral parasitaemia and suggests the role of pro-inflammatory cytokines in 
mediating this process.
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5.1 Introduction 
The lack of correlation between peripheral parasitaemia and anaemia in severe 
malarial anaemia suggests that factors besides schizont rupture and 
erythrophagocytosis contribute to anaemia. It is well documented that 
proinflammatory cytokines such as TNF-α, IFN-γ and IL-6 have an adverse effect on 
erythroid development, leading to anaemia in multiple diseases including chronic 
infections, chronic inflammatory diseases, myelodysplastic syndromes and 
malignancy (113,115,151–157). In malaria, it has been proposed that these 
proinflammatory cytokines play a central role in mediating mechanisms that lead to 
anaemia (105,158,159). 
My observation in the preceding chapter that the suppression of erythropoiesis in the 
BM during experimental malaria can be observed in models which are characterised 
by high as well as low peak parasitaemia, strongly suggests that the blood stage 
parasite antigens and/or by-products of parasite-driven haemoglobin catabolism, 
such as hemozoin, are sufficient to elicit a robust proinflammatory cytokine response, 
capable of suppressing erythroid development in the BM. 
In a murine model of anaemia of chronic disease, the anaemia in these mice was fully 
dependent on IFN-γ mediated upregulation of the transcription factor Pu.1, a known 
antagonist of the erythroid transcription factor GATA-1 (113). In this model, IFN-γ was 
responsible for the reduced life span of red blood cells and the inhibition of BM 
erythroid output. There was no evidence for increased apoptosis of erythroblast 
populations in this study. 
In studies in vitro, the induction of apoptosis in erythroid cells has been the central 
mechanism by which IFN-γ indirectly mediates the suppression of erythropoiesis, but 
in in-vivo settings and particularly during malaria, the specific pathways linking IFN-γ 
to dyserythropoiesis are poorly defined. Furthermore, It remains unknown if the 
suppression of erythropoiesis by IFN-γ is a consequence of a direct signalling in 
haematopoietic cells especially in cells of the erythroid lineage or whether it is a 
consequence of IFN-γ signalling in non-haematopoietic compartments such as the 
mesenchymal-derived subsets of niche-forming cells. 
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The purpose of this study was to determine in vivo, if the ablation of IFN-γ signalling 
in the haematopoietic compartment alone was sufficient to abate BM suppression 
during malaria, resulting in increased BM and splenic erythroid output. To address 
this question, I have taken advantage of the Cre/loxP recombination system (160). I 
used tissue-specific conditional knockout mice in which the Ifngr2 gene, which 
encodes the IFN-γ receptor β chain was specifically deleted on all haematopoietic 
cells.  
The α chain of IFN-γ receptor is the ligand binding component while the β chain is 
responsible for downstream signalling (161). By deleting Ifngr2 strictly on only the 
haematopoietic cells in the Vav1::iCre/Ifngr2fl/fl mice, I expected that all 
haematopoietic cells in this strain of mice would be incapable of IFN-γ signalling while 
the Ifngr2fl/fl and Vav1::iCre mice serving as controls would have intact IFN-γ 
signalling. 
5.2 Ablation of IFN-γ signalling in haematopoietic cells 
does not alter the number of erythroid and myeloid 
progenitors in steady state  
Prior to establishing experimental malaria, I determined if mice that had undergone 
ontogeny in the absence of IFN-γ signalling in haematopoietic cells would result in 
changes in their number of HPC sub-populations in comparison to mice with intact 
IFN-γ signalling. Live LIN— cells from naïve Vav1::iCre/Ifngr2fl/fl, Vav1::iCre and  
Ifngr2fl/fl mice were labelled with fluorochrome conjugated monoclonal antibodies 
against CD117, Sca-1, CD150 and CD27 as described in preceding chapter, and the 
absolute number of MEP, Pre-MEP and CMP/GMP was determined. I observed no 
significant difference in the absolute number of these progenitor populations in IFN-γ 













Figure 5.1 Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice exhibit no 
difference in absolute number of HPC subsets in steady state 
Absolute number per femur/tibia pair of MEP, Pre-MEP and CMP/GMP in Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl 
and Vav1::iCre mice in steady state. Results are representative of two independent experiments. 
Values represent mean ± SEM, n = 10 mice per group. Significance was calculated using one-way 
ANOVA. 
5.3 Upregulation of Sca-1 on HPCs during malaria is 
directly dependent on IFN-γ signalling in 
haematopoietic cells 
Next, I established experimental malaria in IFN-γ signalling deficient  and control 
mice. Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice were infected intraperitoneally 
with 105 Pcc AS parasitised erythrocytes using the SBP model of infection and the 
upregulation of Sca-1 on cells within the HPC pool was evaluated. Our laboratory 
previously demonstrated both in vitro and in vivo that upregulation of Sca-1 on HPCs 
is dependent on IFN-γ signalling in these cells (68). This experiment served two 
purposes in this current study: It served as a functional read-out to confirm the 
genotype of mice used in this study and to ascertain whether the deletion of the 
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during malaria, thereby confirming the absence of down stream signalling despite the 
receptor being able to bind to its ligand via the α chain. 
At days 5 and 7 post-infection, I observed no change in surface expression of Sca-1 
on HPC subpopulations in Vav1::iCre/Ifngr2fl/fl mice, whereas in control mice, 
upregulation of Sca-1 on HPC subsets had set in at day 5 post-infection (Figure 5.2A), 
with much greater upregulation at day 7 post-infection (Figure 5.2B). These 
observations are in agreement with previous work in our lab in which mice that lacked 
the α chain of the IFN-γ receptor on all cells (Ifngr1-null) failed to upregulate Sca-1 
during malaria, whereas mice with the intact receptor upregulated Sca-1 on their 
surface(68). These observations were expected considering that that Ly6a which 











Figure 5.2 Vav1::iCre/Ifngr2fl/fl mice do not upregulate Sca-1 during malaria. 
Representative FACS plots illustrating the upregulation of Sca-1 on HPCs at (A) day 5 (B) day 7 
post-infection in Ifngr2fl/fl and Vav1::iCre mice, whereas HPCs in Vav1::iCre/Ifngr2fl/fl mice failed to 
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upregulate Sca-1 during experimental malaria. Data is representative of two independent experiments 
using three to five mice per group in each experiment. 
 
5.4 IFN-γ signalling in haematopoietic cells is crucial for 
malaria parasite control  
There have been several correlations between circulating levels of IFN-γ and 
protection against severe malaria in humans. IFN-γ has been implicated in mediating 
protective immunity against the pre-erythrocytic and erythrocytic stages of malaria 
parasites(163–165). In the Fulani tribe in Mali which are naturally resistant to 
P. falciparum malaria there was a much stronger inverse correlation between parasite 
density and circulating IFN-γ levels in comparison to surrounding tribes (166). In 
murine models of malaria (using P. chabaudi and P. yoelii), IFN-γ deficient mice had 
more elevated and prolonged parasitaemia than control mice (167). 
To further dissect the contribution of IFN-γ signalling in haematopoietic cells in the 
control of parasite density, I monitored the course of parasitaemia in female 
Vav1::iCre/Ifngr2fl/fl and control mice during the acute phase of Pcc AS malaria by 
examination of thin blood smear. Following infection with 105 Pcc AS parasitised 
erythrocytes, peak parasitaemia was observed at day 7 post-infection in IFN-γ 
deficient and control mice (Figure 5.3A), and at this time point, parasitaemia was 
significantly higher in IFN-γ deficient mice compared to control mice (Figure 5.3B). 
My results suggest that intact IFN-γ signalling in haematopoietic cells contributes in 
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Figure 5.3 IFN-γ signalling in haematopoietic cells is crucial for malaria 
parasite control 
Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice were infected with 105 Pcc AS parasitised 
erythrocytes using the SBP model of infection. (A) Course of experimental malaria in 
Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice. Parasitaemia was determined on the indicated days. 
(B) Parasitaemia at day 7 post-infection in Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice. (A,B) Data 
represents results from two independent experiments, values represent mean ± SEM, n=10 Pcc AS 
infected Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice and 6 Pcc AS infected Vav1::iCre mice per time point. 
Significance was calculated using one-way ANOVA and Tukey multiple comparisons test. Asterisks 
represent statistically significant differences (ns: not significant; *: P<0.05; **: P<0.01). 
 
5.5 Contraction of Lineage negative bone marrow cells 
during acute malaria is dependent on IFN-γ signalling 
in haematopoietic cells. 
During acute Pcc AS malaria in WT C57BL/6 mice, I observed a contraction in the 
absolute number per femur tibia pair of LIN— BM cells (Figure 4.1C). Our laboratory 
previously showed that this contraction is dependent on IFN-γ signalling coupled with 
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chimaeras, the effect of IFN-γ signalling on the loss of myeloid committed BM 
progenitors was attributed to an irradiation insensitive cellular component in that 
study. 
Adopting a refined genetic approach in this study, Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and 
Vav1::iCre mice were infected with 105 Pcc AS parasitised erythrocytes using the SBP 
model of infection. At day 5 and 7 post-infection BM was obtained and labelled with 
FITC conjugated monoclonal antibodies against lineage markers as described in 
preceding chapters. After excluding doublets, dead cells and FITC positive cells, the 
frequency and absolute number of residual LIN— cells was determined. At day 7 
post-infection which corresponds to peak parasitaemia, the frequency (Figure 5.4A) 
and absolute number per femur/tibia pair (Figure 5.4B) of LIN— cells was significantly 
higher in IFN-γ signalling deficient mice in comparison to controls. The contraction of 
BM LIN— cells observed in WT C57BL/6 mice in preceding chapter as well as in 
Ifngr2fl/fl and Vav1::iCre mice was completely abolished in Vav1::iCre/Ifngr2fl/fl mice. 
Taken together, this data suggests that the contraction of LIN— BM cells during 
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Figure 5.4 Loss of LIN— BM cells during P. chabaudi malaria is dependent on 
IFN-γ signalling in haematopoietic cells 
Frequency (A) and Absolute number per femur/tibia pair (B) of LIN— BM cells in Vav1::iCre/Ifngr2fl/fl, 
Ifngr2fl/fl and Vav1::iCre mice. The cells in the LIN— gate are sparsely distributed in control mice in 
comparison to IFN-γ signalling deficient mice. Data represents results from two independent 
experiments, values represent mean ± SEM, n=10 Pcc AS infected Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl 
mice and 6 Pcc AS infected Vav1::iCre mice per time point. Significance was calculated using one-
way ANOVA and Tukey multiple comparisons test. Asterisks represent statistically significant 
differences (***: P<0.001). 
 
5.6 IFN-γ signalling in haematopoietic cells is crucial for 
malaria dyserythropoiesis in bone marrow and spleen 
To dissect the role of IFN-γ signalling on aberrant erythropoiesis during malaria, I 
infected female Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice with 105 Pcc AS 
parasitised erythrocytes and at days 5 and 7 post-infection, I determined the 
frequency and absolute numbers of MEP, Pre-MEP and CMP/GMP analogues ( in the 
BM alone), and erythroid precursors (in the BM and spleen). Naive age and 
gender-matched littermate Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice were 
used as controls. Prior to infection and at several time points during infection, the 
serum concentration of IFN-γ and TNF-α was determined. 
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In the BM at day 5 post-infection, I observed a higher frequency of the CMP/GMP 
analogue and a lower frequency of the MEP analogue in IFN-γ deficient mice in 
comparison to controls (Figure 5.5A). Despite the higher frequency of the MEP 
analogue in the controls, the contour lines within the MEP analogue gate were more 
closely packed in IFN-γ signalling deficient mice than in controls indicating a higher 
concentration of events. Considering that the same number of events was acquired 
on the cytometer for IFN-γ signalling deficient and control mice, suggested that the 
frequency of the MEP analogue might not correlate with the absolute number in this 
instance. 
There was an increase in the absolute number of the MEP analogue during infection 
regardless of genotype but no significant difference in the magnitude of this increase 
was observed between IFN-γ signalling deficient and control mice (Figure 5.5B). The 
contraction of the Pre-MEP analogue was evident in control mice, whereas in mice 
lacking IFN-γ signalling, this population remained stable during infection. Despite the 
infection induced contraction of the CMP/GMP analogue in all strains, the absolute 
number of this population remained significantly higher in Vav1::iCre/Ifngr2fl/fl mice in 
comparison to control mice. Contrary to previous work in our lab (68), this finding 
indicates that IFN-γ signalling in haematopoietic cells is crucial for the contraction of 
myeloid progenitors during malaria. 
At day 7 post-infection, I observed an even greater reduction in the frequency of 
CMP/GMP analogue in control mice (Figure 5.5C). Similar to day 5, the frequency of 
the MEP analogue in IFN-γ signalling deficient mice was much lower than in control 
mice but the contour lines indicated a higher concentration of events in this group. 
Indeed, the absolute number of MEP analogue in Vav1::iCre/Ifngr2fl/fl mice was 
significantly higher than in Ifngr2fl/fl mice (Figure 5.5D). The absolute number of 
Pre-MEP analogue remained stable in IFN-γ signalling deficient mice and was 
significantly higher than in infected controls. There was a further reduction in the 
absolute number of CMP/GMP analogue in infected controls, while in IFN-γ signalling 
deficient mice the contraction of this population at day 7 post-infection was similar 
to day 5. 
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Figure 5.5 Suppression of erythroid progenitor expansion in the BM during 
malaria is dependent on IFN-γ signalling in haematopoietic cells 
LIN— BM cells from Pcc AS infected and naïve Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice were 
labelled with monoclonal antibodies against CD117, Sca-1, CD150 and CD27. Frequency of MEP, 
Pre-MEP and CMP/GMP analogues at (A) day 5 and (C) day 7 post-infection. Absolute number per 
femur/tibia pair of MEP, Pre-MEP and CMP/GMP analogues at (B) day 5 and (D) day 7 post-infection. 
Data represents results from two independent experiments, values represent mean ± SEM, n=10 
Pcc AS infected Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice and 6 Pcc AS infected Vav1::iCre mice per time 
point. Significance was calculated using one-way ANOVA and Tukey multiple comparisons test. 
Asterisks represent statistically significant differences (*: P≤0.05, **: P≤0.01, ***: P≤0.001, 
****: P≤0.0001). 
 
BM erythroid precursors were identified as described in preceding chapters. At day 5 
post-infection, the 1:2:4:8 ratio of erythroblast maturation was unperturbed with 
similar frequency of erythroid precursors in Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and 
Vav1::iCre mice (Figure 5.6A). This reflected in the absolute number of erythroid 
precursors with no significant difference observed in infected Vav1::iCre/Ifngr2fl/fl, 
Ifngr2fl/fl, Vav1::iCre and naïve C57BL/6 mice (Figure 5.6B). At day 7 post-infection, 
there was a reduction in the frequency of erythroid precursors in control mice 
Pcc AS day 7 
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whereas in IFN-γ signalling deficient mice the frequency of erythroid precursors 
remained stable (Figure 5.6C). Furthermore, I observed a significant reduction in the 
absolute number of erythroblasts at each stage of maturation in control mice in 
comparison to IFN-γ signalling deficient mice (Figure 5.6 D). Surprisingly, the absolute 
number of basophilic and polychromatic erythroblasts was significantly higher in 
infected Vav1::iCre/Ifngr2fl/fl mice than in naïve C57BL/6 mice, suggesting some 
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Figure 5.6 Contraction of erythroid precursors in the BM during malaria is 
dependent on IFN-γ signalling in haematopoietic cells 
Frequency of BM erythroid precursors in Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice at (A) day 5 
and (C) day 7 post-infection. Absolute number per femur/tibia pair of BM erythroid precursors in naïve 
C57BL/6 and infected Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice at (B) day 5 and (D) day 7 
post-infection. Data represents results from two independent experiments, values represent mean ± 
SEM, n=10 Pcc AS infected Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice and 6 Pcc AS infected Vav1::iCre 
and naïve C57BL/6 mice per time point. Significance was calculated using one-way ANOVA and Tukey 
multiple comparisons test. Asterisks represent statistically significant differences (*: P≤0.05, 
**: P≤0.01, ***: P≤0.001, ****: P≤0.0001). 
 
Next, spleens from infected Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice were obtained and 
weighed then erythroid precursors in the spleen were identified as described in 
preceding chapters. At days 5, 7 and 9 post-infection, I observed that the spleens 
from Vav1::iCre/Ifngr2fl/fl  mice weighed significantly less than infected control mice 
(Figure 5.7A) and were considerably smaller. (Figure 5.7B). The absence of IFN-γ 
signalling to mobilise myeloid progenitors from the BM to the spleen could have 
contributed to the smaller spleen size in Vav1::iCre/Ifngr2fl/fl mice. In addition, the 
spleens from infected Vav1::iCre/Ifngr2fl/fl  mice were slightly larger than naïve 
Pcc AS day 7 
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C57BL/6 mice. This suggests that other factors besides IFN-γ signalling in 
haematopoietic cells, such as accumulation of parasitised erythrocytes contribute to 
splenomegaly during malaria. At day 7 post-infection, the frequency of all 
erythroblasts was significantly higher in Vav1::iCre/Ifngr2fl/fl mice than in Ifngr2fl/fl mice 
(Figure 5.7C). This reflected in the absolute numbers, with a significantly higher 
absolute number of all erythroblasts in Vav1::iCre/Ifngr2fl/fl mice in comparison to 
control mice (Figure 5.7D). These observations suggest that the block in 
erythropoiesis in the spleen, described in Chapter 4 is ameliorated in the absence of 
IFN-γ signalling in haematopoietic cells. 
Following binding of IFN-γ to its cognate receptor, there is a rapid internalisation of 
the cytokine-receptor complex (168). Unpublished data from our lab showed that 
T cells from Vav1::iCre/Ifngr2fl/fl mice stain positive for Ifngr1, indicating its presence 
in the mutant. To decipher whether the interactions between IFN-γ and the ligand 
binding component of the IFN-γ receptor affects serum levels of IFN-γ with respect 
to its internalisation and degradation in the absence of the β-chain, I measured 
circulating levels of IFN-γ in mice lacking the b-chain and those with the intact 
receptor. I hypothesised that the more this cytokine was internalised and degraded, 
the lesser would be its concentration in circulation. I observed no significant 
difference in the serum levels of IFN-γ in Vav1::iCre/Ifngr2fl/fl and control mice 
(Figure 5.7E) suggesting that IFN-γ internalisation, degradation and receptor 
recycling might nοt be dependent on the b-chain. The spike in serum concentration 
of IFN-γ was transient and could only be detected after day 3 post-infection by ELISA. 
I also determined the circulating levels of TNF-α and similar to earlier experiments in 
C57BL/6 mice, the peak was observed at day 7, much later than the peak of IFN-γ.  
In this study, the serum concentration of TNF-α was much higher in 
Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice than in C57BL/6 (discussed in 
Chapter 4) which might be due to differences in genetic background. 
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Figure 5.7 Contraction of erythroid precursors in the spleen during malaria is 
dependent on IFN-γ signalling in haematopoietic cells 
(A) Bar chart showing the mass per spleen of Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice at days 5, 7 and 9 
post-infection. (B) Representative image showing the spleens of Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice 
at day 9 post-infection as well as spleen from naïve C57BL/6 mice. (C) Representative FACS plots 
illustrating the frequency of splenic erythroid precursors in Vav1::iCre/Ifngr2fl/fl and Ifngr2fl/fl mice at day 
7 post-infection. (D) Absolute number per spleen of erythroid precursors in Vav1::iCre/Ifngr2fl/fl and 
Ifngr2fl/fl mice at day 7 post-infection. (E) Serum concentration of IFN-γ and TNF-α in 
Vav1::iCre/Ifngr2fl/fl, Ifngr2fl/fl and Vav1::iCre mice throughout infection.  
(A and E) Data represents results from two independent experiments, values represent mean ± SEM, 
n=10 Pcc AS infected Vav1::iCre/Ifngr2fl/fl and 6 Ifngr2fl/fl mice  per time point. (C and D) Data 
represents results from one experiment, values represent mean ± SD, n=10 Pcc AS infected 
Vav1::iCre/Ifngr2fl/fl and 8 Ifngr2fl/fl mice  per time point. (A and D) Significance was calculated using 
Student’s t-test(*: P≤0.05, **: P≤0.01). (E) Significance was calculated using one way ANOVA. 
 
5.7 Discussion 
It has been known mostly from in vitro studies that IFN-γ is a potent mediator of 
dyserythropoiesis. In malaria however, the role of IFN-γ in mediating erythroid 
suppression is still elusive and I attempted to dissect the role of IFN-γ in vivo. The 
availability of mice with a specifc ablation of IFN-γ signalling in the haematopoietic 
compartment was exploited to study the role of IFN-γ during acute malaria in a mouse 
model. The use of the genetically engineered strain eliminates the need for mixed BM 
chimaera thereby allowing the study of the infection-induced effect of IFN-γ. 
I confirmed the absence of IFN-γ signalling using two independent means: Successful 
Cre-dependent ablation of Ifngr2, and using the upregulation of Sca-1 as a functional 
read-out of IFN-γ signalling. The proto-oncogene Vav1 is a protein encoded by the 
Vav1 gene, whose expression is predominantly restricted to all haematopoietic cells 
regardless of stage of development and lineage (169). The upregulation of Sca-1 
during infection is dependent on intact IFN-γ signalling (68), and this was used to 
confirm that the Vav1::iCre/Ifngr2fl/fl mice were deficient in IFN-γ signalling exclusively 
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in haematapoietic cells while both the Ifngr2fl/fl and Vav1::iCre mice had intact IFN-γ 
signalling. 
The importance of IFN-γ in enhancing the phagocytic activity of myeloid cells to 
control parasite growth was clearly evident in this study, in that Vav1::iCre/Ifngr2fl/fl 
mice had significantly higher parasitaemia in comparison to mice with intact IFN-γ 
signalling. As I had previously demonstrated that erythroid suppression during 
malaria was independent of the degree of peripheral parasite density, this difference 
in parasitaemia between mice deficient in IFN-γ signalling and control mice would not 
have contributed to any observed difference in erythroid suppression in these mice. 
I have shown for the first time in an in vivo setting, that at early time points during 
experimental malaria, IFN-γ signalling in haematopoietic cells is a crucial element in 
the infection-induced suppression of erythroid development in the BM and spleen. 
Applying a more refined phenotypic approach than has been defined previously (19), 
I demonstrated that the suppression of erythroid development during malaria afffects 
more primitive progenitor subsets than was previously thought, suggesting a 
functional impact already in HSCs and multipotent progenitors. In addition, I showed  
that the splenomegaly during malaria cannot be attributed exclusively to an increased 
erythropoiesis based on the key observation of absence of more differentiated 
erythroid precurors. 
Using mixed BM chimaeras in which lethally irradiated C57BL/6 mice were 
transplanted with BM from Ifngr1-null mice, our laboratory previously showed that 
the mobilisation of the myeloid progenitors out of the BM into the spleen was an 
indirect consequence of IFN-γ signalling via the stromal compartment (68). Using a 
refined, genetically based system, which avoids transplantation, I have described a 
hitherto undetectable direct effect of IFN-γ on the myeloid progenitor compartment. 
This suggests that IFN-γ signalling via the haematopoietic and stromal compartments 
could both be playing a role in this egress of myeloid progenitors from the BM in the 
context of malaria. My findings are in agreement with MacNamara and colleagues 
(135) who demonstrated in a murine model of human monocytic ehrlichiosis that the 
mobilisation of myeloid progenitors from the BM is a direct consequence of IFN-γ 
signalling in haematopoietic cells. The efflux of myeloid progenitors from the BM to 
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the spleen as well as the contraction of the pre-MEP analogue in the Ifngr2fl/fl and 
Vav1::iCre control mice might account for the contraction of the LIN— BM cells in 
these mice. 
The unexpected significant increase in the basophilic and polychromatic erythroblast 
stages in the BM of Pcc AS infected Vav1::iCre/Ifngr2fl/fl mice, in comparison to naive 
C57BL/6 mice, suggests some degree of erythroid response to malaria in these 
populations. This implies that in the absence of IFN-γ signalling in haematopoietic 
cells, the expansion of the MEP in the BM and spleen reflects in the number of 
downstream erythroid precursors at both sites during malaria.  
There was no significant change in the kinetics of IFN-γ in mice lacking Ifngr2 in 
comparison to control mice. To further investigate if IFN-γ internalisation, degradation 
and receptor recycling might be dependent on Ifngr2, a comparison of the 
intracellular concentration of IFN-γ between Ifngr2 deficient cells that do not 
synthesise the protein (to eliminate the need to distinguish internalised from newly 
synthesised protein) and Ifngr2 expressing cells after IFN-γ stimulation is required. 
5.8 Conclusion 
In summary, at early time points during experimental malaria, there is an IFN-γ 
dependent suppression of erythropoiesis in the BM and spleen that impacts multiple 
stages of erythroid development including the most primitive erythroid progenitor the 
Pre-MEP. The exact mechanism by which IFN-γ mediates this suppression is still 
unknown but might be due to lateral inhibition of erythropoietin signalling and/or 
apoptosis. This is discussed further in Chapter 6. My findings do not exclude the 
impact of other potential mediators of dyserythropoiesis during malaria such as 
TNF-α, however, they could be acting at much later time points. 
Knowledge of the exact concentration of proinflammatory cytokines in particular, 
IFN-γ and TNF-α in the BM and spleen during malaria could provide useful insights 
into the spatial and temporal impact of these cytokines on erythroid development. To 
draw conclusions on the direct effect of Pcc AS on erythroid development, there is a 
need to measure the parasite density in the BM during the course of malaria. 
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In agreement to previous studies, I documented the importance of IFN-γ signalling in 
haematopoietic cells for the control of parasite growth. However, results might differ 
depending on the malaria model in use, and indeed there is a study showing that the 
early induction of IFN-γ in a murine model of P. yoelii malaria favoured the 
parasitaemia at early time points, but at later time points in this study, IFN-γ was 
crucial in efficiently clearing the blood stage parasite (170). 
In this study I was unable to determine if the expansion of the MEP analogue in the 
spleen was as a result of the migration of BM MEP or upstream progenitors to the 
spleen, the proliferation of native splenic MEP and/or the increased differentiation of 
upstream splenic erythroid progenitors. Further research is required to decipher 
which of these processes might prevail during malaria. 
Future work could focus on recent advances in single-cell RNA sequencing and 
transcriptomics to explore the molecular mechanism for IFN-γ dependent 
suppression of erythropoiesis during malaria . Changes that occur in key erythroid 
transcription factors such as GATA-1, GATA2, EKLF and FOG-1 in steady state and 
during malaria as well as transcriptional changes in pro-apoptotic genes such as Bax; 
and anti-apoptotic genes such as Bclxl could  be determined. In this study I have 
restricted the ablation IFN-γ signalling to all haematopoietic cells, this can be 
improved upon by restricting the ablation of IFN-γ signalling to erythroid cells using 
the EpoR-Cre, Ifngr2fl/fl mice. 
.
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One of the most life-threatening complications of malaria is severe anaemia. In 
holo-endemic transmission areas, severe malarial anaemia (SMA) is the main clinical 
manifestation of severe childhood malaria. In these high transmission areas, mortality 
rates can exceed 30% in children (171). Management of patients with SMA is mainly 
by blood transfusion, however, in resource-poor settings in sub-Saharan Africa, there 
are several risks to life and health posed by blood transfusion. Rather than managing 
SMA, understanding the pathogenesis and devising measures to eliminate the drivers 
seems a much better approach. 
One driver of SMA is suppressed erythropoiesis. Administration of erythropoietin and 
erythropoietin stimulating agents (ESAs) have been used in the treatment of anaemia 
of chronic kidney disease. However, they fail to stimulate erythropoiesis in individuals 
with SMA (172) because these individuals are not deficient in erythropoietin 
production. On the contrary, these patients have a robust erythropoietin response to 
malaria (139) but are nonresponsive to the hormone evidenced by the low RPI. 
Ferrous iron supplements have had the worse outcomes and had to be prematurely 
stopped. Of recent, triterpenes with pleiotropic (anti-inflammatory, anti-nociception, 
antioxidant) properties have been reported as having much potential in the treatment 
of SMA in murine models (172). Several proinflammatory cytokines such as TNF-α, 
IFN-γ and IL-6 have been implicated as mediators of dyserythropoiesis in multiple 
diseases. Considering the early spike in IFN-γ concentration in serum in murine 
models of malaria, and unpublished data from our lab that there is an expansion of 
erythroid progenitors in Ifngr1-null mice during malaria, I have focussed on IFN-γ in 
this study. I aimed to investigate the role of IFN-γ in mediating suppressed 
erythropoiesis during malaria. 
The suppression of erythropoiesis during malaria has been demonstrated in several 
studies, however, there is a paucity of data on the in-vivo role of IFN-γ in mediating 
this erythroid suppression during malaria. Furthermore, there exists no published 
study that has utilised the most recent gating strategies to identify erythroid cells 
during malaria. Suppression of erythropoiesis is not unique to malaria, it occurs also 
in Leishmaniasis and has been attributed to cytokine mediated apoptosis of 
erythroblasts (173). 
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6.1 Steady state erythropoiesis 
Studies on dyserythropoiesis in malaria have mainly focussed on the BFU-e, CFU-e 
and reticulocyte stages of erythropoiesis. Unfortunately, the transition from the HSC 
compartment into the most mature precursors of the erythroid lineage has not been 
comprehensively mapped. I set out to identify erythroid progenitors and precursors 
using the most recent gating strategies. Akashi et al.(12) pioneered the identification 
of the MEP using the surface markers CD16/32 and CD34. The MEP was previously 
thought to be the earliest erythroid progenitor downstream of the MPPs, but Pronk 
and colleagues (19) demonstrated using the surface marker CD150, that it is a 
heterogeneous population containing both CD150+ and CD150— subsets. The 
CD150+ subset was termed pre-MEP (precursor of MEP). CD150, a SLAM-family 
member, is a marker expressed on HSCs, and its expression on the pre-MEP 
suggested that it was more primitive than the MEP. Due to the poor resolution of cells 
within the HPC compartment by CD34, and considering that all the myeloid 
progenitors within this compartment express CD27, I used CD27 which provides a 
much better resolution, to distinguish the myeloid progenitors (CMP and GMP) from 
the MEP and pre-MEP. I also used CD150 to distinguish the pre-MEP from the MEP. 
Next, I went further to confirm the erythroid potential of these populations in vitro. I 
demonstrated that the pre-MEP is a direct precursor of the MEP. Furthermore, MEPs 
cultured in vitro under erythroid conditions resulted in the acquisition of Ter119. The 
marker combination of CD150 and CD27 represents a significant advancement for 
the dissection of erythroid-committed progenitors and a yet unknown refinement in 
the study of erythropoiesis. In addition, antigen density of CD27 was found 
unchanged during infection as shown previously (68). Erythroid precursors were 
identified using a novel gating strategy in which the ratio of proerythroblast via 
basophilic erythroblast, polychromatic erythroblast to orthochromatic erythroblast, 
relate to each other in a 1:2:4:8 ratio during terminal differentiation in steady state. 
This ratio was found to be perturbed during malaria indicating either a cessation of 
proliferation and/or a defect in terminal differentiation. 
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6.2 Erythroid development during malaria 
Using this novel gating strategy, I investigated the changes that occurred in erythroid 
progenitors and precursors during malaria. In three models of malaria namely the SBP 
model, the MT model and SI model which differ in the immune response elicited, 
cytokine induction, parasite density and parasite virulence, erythroid suppression 
was evident to similar degree. I observed an expansion of the BM MEP analogue and 
a contraction of downstream BM erythroid precursors. The contraction of Ter119+ 
erythroblast populations during malaria has been well documented and my findings 
are in full agreement with previous studies (95,150,174,175). I extended my 
investigations to include erythroid-committed populations upstream of the MEP 
during malaria. 
The failure of the increased number of BM MEPs to reflect in downstream stages 
could have been due to their translocation from the BM to the spleen, or as a result 
of a block in downstream differentiation. To further clarify this, a similar phenotypic 
approach to map erythroid development was employed for spleen-resident cells. 
There was approximately an 18-fold increase in the number of MEP analogue in the 
spleen of infected mice during malaria but similar to the BM, this highly significant 
expansion of MEPs was not reflected in the number of more distal erythroblast 
populations. Despite the possibility of MEP migration from the BM to spleen, there 
was a clear block in erythroid development which was independent of parasite 
density. These observations are similar to b-thalassemia dyserythropoiesis in humans 
which is characterised by expansion of early erythroid progenitors and a contraction 
of downstream stages (176). 
While the BM MEP analogue expanded during malaria, there was no change in the 
CD27int fraction of the HPC, which contains the pre-MEP analogue, in two models of 
malaria, namely the SBP and SI, while in the MT model, there was a contraction of 
this population. Considering that this population is upstream of the MEP suggests 
that the suppressive effect on erythropoiesis during malaria could be occurring at 
multiple stages. As previously published (68,124), serum concentration of IFN-γ 
peaked at day 5 post infection. During malaria, specific CD4+ T-cells are the main 
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cellular source of the transient IFN-γ production (177–179). The number of IFN-γ 
secreting T cells was significantly higher in the spleen compared to the BM 
(unpublished results, Belyaev et al.). In summary, this suggests a higher local 
concentration of IFN-γ in the spleen compared to the BM arguing for the higher 
degree of erythropoietic suppression observed in the spleen. Since no qualitative 
difference in erythroid suppression in all three murine models of malaria were 
recorded, I concentrated on the SBP model, since it exhibits a clear temporal 
dissociation in the peak levels of IFN-γ and TNF-α, whereas in the MT model, the 
kinetics overlap (124). This allows to dissect the distinct suppressive effect of IFN-γ 
versus TNF-α during acute malaria infection. 
6.3 Erythroid development during malaria in tissue specific 
absence of IFN-γ signalling. 
During experimental malaria infections, our laboratory demonstrated a dynamic 
remodelling of several developmental compartments in the BM which depended on 
IFN-γ signalling either directly (lymphoid and erythroid compartment) or indirectly 
(myeloid compartment). IFN-γ is a potent suppressor of haematopoiesis (180–182) 
and has been implicated in the pathology of several diseases. IFN-γ promotes 
experimental cerebral malaria in mice models by signalling in haematopoietic and 
non-haematopoietic compartments (183). Furthermore, IFN-γ-1616 C/T 
polymorphism in humans was associated with higher serum concentration of IFN-γ 
and susceptibility to P. falciparum malaria (184). 
I investigated whether IFN-γ signalling in haematopoietic cells alone is responsible 
for the suppression of erythropoiesis during malaria. In this study, I made use of a 
refined genetically engineered mouse strain in which Ifngr2, the signalling component 
of the receptor, was deleted exclusively on haematopoietic cells. IFN-γ has been 
reported to modify the expression of Sca-1 on T-cells (185), B cells (186), GMPs, 
CMPs and MEPs (68). In this study, I demonstrate that IFN-γ signalling in 
haematopoietic cells is crucial for the upregulation of Sca-1 on HPCs, which 
correlates with previous findings in our lab in which HPCs in Ifngr1-null mice failed to 
upregulate Sca-1 on their surface. 
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It has been reported in several studies that IFN-γ is necessary for the control of 
malaria parasite (167,187), I observed that mice lacking IFN-γ signalling in 
haematopoietic cells had a significantly elevated parasitaemia in comparison to 
wildtype controls. This was not surprising as IFN-γ is a known activator of phagocytic 
cells enhancing their microbicidal activities (188,189) 
At day 5 post-infection, there was a significant expansion in the MEPs in both IFN-γ 
signalling deficient mice and wild type controls in comparison to naive controls, at 
day-7 post infection however, the absolute number of MEPs in infected wild type 
mice contracted and was similar to naive controls. In contrast, in infected mice 
deficient in IFN-γ signalling, the MEPs were still significantly elevated. In the pre-MEP 
population, a significant contraction had already set in at day 5 post-infection, in 
infected wild type mice, with an even greater contraction at day 7 post-infection but 
in infected mice deficient in IFN-γ signalling, no contraction in the number of the 
pre-MEPs was observed and there was no difference in comparison to naive controls. 
In addition, no difference in the absolute numbers of erythroid precursors was 
observed between infected and naive mice at day 5 post-infection, but at day 7 
post-infection, there was a significant contraction in erythroblast populations in 
infected wild type mice, whereas, in infected mice deficient in IFN-γ signalling, no 
contraction was observed. In fact, there was a significant increase in the absolute 
numbers of basophilic erythroblasts and polychromatic erythroblasts in comparison 
to naive wild type mice. The lack of significant difference in the absolute numbers of 
the most mature erythroblast population, the orthochromatic erythroblast, in mice 
lacking IFN-γ signalling and wild type control, suggests that erythropoietic 
suppression in the BM might manifest first on the primitive erythroid populations and 
affects more differentiated populations only at later time-points. This might indicate 
a different level of IFN-γ susceptibility in different subsets. Similar to the BM, spleens 
of mice deficient in IFN-γ signalling, had significantly higher frequency and absolute 
number of erythroid precursors in comparison to wild type controls. 
Putting all together, this study has demonstrated that IFN-γ signalling in 
haematopoietic cells alone is crucial for the early suppression of BM and splenic 
erythropoiesis during malaria in a cell-autonomous way. However, it does not rule out 
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the contribution of other mediators, such as TNF-α or haemozoin, at later time points 
in malaria. Furthermore, considering that the most primitive erythroid biased 
population within the HPC compartment, the pre-MEP, was suppressed by malaria, 
it raises the possibility that the earliest hit could be occurring in cells within the LSK 
pool. The amalgamation of the HPC and LSK pools during malaria clearly indicate the 
need for a further set of parameters to identify cells with impaired erythroid function. 
The suppression of erythropoiesis and the expansion of myeloid progenitors during 
malaria might be an evolutionary strategy by the host to restrict the availability of cells 
that the pathogen can infect while producing more of those cells that are capable of 
eliminating the parasite. In this situation IFN-γ clearly would be the ideal mediator of 
both suppression and activation either directly or indirectly. 
6.4 Future direction 
As with most research, this study can be explored further. It is not clear if the striking 
expansion of the MEP analogue in the spleen is a consequence of their migration 
from the BM, a proliferation of native splenic erythroid progenitors or a combination 
of both, hence, this will be a subject for further research. In studies in vitro, IFN-γ 
mediated suppression of erythroid development through two main mechanisms; 
apoptosis and upregulation of antagonists of key erythroid transcription factors 
(113,117). Insight into the potential mechanisms by which IFN-γ mediates 
suppression of erythropoiesis during malaria can be gained by determining the 
changes that occur in key erythroid transcription factors such as GATA-1, GATA-2, 
EKLF and FOG-1 and their antagonists such as Pu.1. Transcriptional changes in 
pro-apoptotic genes such as Bax; and anti-apoptotic genes such as Bclxl in mice with 
tissue specific ablation of IFN-γ signalling could also be determined. Erythropoietin 
signalling in erythroid cells was demonstrated to be crucial for survival by inhibiting 
apoptosis in these cells (190). Furthermore, there is a joint requirement of Jak2 for 
downstream signalling by both EpoR and IFN-γR. Considering the elevated levels of 
IFN-γ during malaria, I hypothesise that there is a bias in the recruitment of Jak2 to 
the b chain of IFN-γR, thereby laterally inhibiting EpoR signalling. This hypothesis can 
be tested in vitro. Immunoprecipitation of EpoR and IFN-γR in MEPs stimulated with 
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Epo and increasing concentration of IFN-γ could be performed to detect the levels of 
phosphorylated Jak2 bound to each receptor. Mass spectrometry-based screening 
platforms could also be used to determine the protein interactome in this population 
during malaria. The findings might explain why erythroid cells in patients with 
dyserythropoiesis do not respond to erythropoietin stimulation despite the high 
serum levels of the growth factor in these individuals. 
In this study the Vav1::iCre driver was used to abolish expression of IFN-γ signalling 
in all haematopoietic cells, this can be refined by restricting the absence of IFN-γ 
signalling to only erythroid cells using a Cre recombinase inserted in the 
erythropoietin receptor gene to ablate expression of IFN-γ receptor β-chain. This will 
provide further insights on the role of IFN-γ signalling exclusively in erythroid-
committed cells and the impact of IFN-γ on malaria dyserythropoiesis. MEPs isolated 
from such a mouse could be useful in the in vitro experiment described above.
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Appendix A: Ifngr2wt/wt locus 
 
 
Primer 1 (5’-TGA GTT CCA AGC AAG ACA GA-3’) anneals at positions 12189bp to 
12208bp, while primer 3 (5’-CAG GGT AGA AAA GAT GTG CA-3’) anneals at 12445bp 







Appendix B: Ifngr2fl/fl locus 
 
The lox-p1 (5’-TGA GTT CCA AGC AAG ACA GA-3’), lox-p 2 (5’-CAG GGT AGA AAA 
GAT GTG CA-3’) and lox-p site (5’-AAG TTA TGG TCT GAG CTC GC-3’) primers 
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